> top > docs > PMC:7306567 > annotations

PMC:7306567 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 1254-1259 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T2 1685-1689 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T3 2464-2474 Body_part denotes neutrophil http://purl.org/sig/ont/fma/fma62860
T4 2490-2494 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T5 2784-2788 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T6 9057-9067 Body_part denotes epithelium http://purl.org/sig/ont/fma/fma9639
T7 9124-9128 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T8 9414-9418 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T9 9419-9425 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T10 9517-9521 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T11 9588-9592 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T12 10370-10375 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T13 10819-10824 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T14 10848-10854 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401
T15 11144-11149 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T16 13374-13379 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T17 13411-13417 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401
T18 14130-14135 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T19 15256-15261 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T20 17083-17089 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T21 17495-17501 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T22 18467-18474 Body_part denotes trachea http://purl.org/sig/ont/fma/fma7394
T23 21837-21843 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T24 22060-22066 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T25 22745-22751 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T26 22752-22756 Body_part denotes Lung http://purl.org/sig/ont/fma/fma7195
T27 22862-22868 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T28 22952-22957 Body_part denotes Serum http://purl.org/sig/ont/fma/fma63083
T29 23069-23075 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401
T30 23181-23186 Body_part denotes Serum http://purl.org/sig/ont/fma/fma63083
T31 23354-23360 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401
T32 23520-23525 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T33 23637-23642 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T34 24072-24078 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401
T35 24304-24309 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T36 24544-24550 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401
T37 25202-25208 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401
T38 25769-25775 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T39 25860-25866 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401
T40 25981-25987 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401
T41 28519-28525 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T42 28789-28794 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T43 29497-29502 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T44 29997-30001 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T45 30251-30255 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T46 30569-30578 Body_part denotes chemokine http://purl.org/sig/ont/fma/fma241981
T47 30589-30597 Body_part denotes monocyte http://purl.org/sig/ont/fma/fma62864
T48 30613-30624 Body_part denotes macrophages http://purl.org/sig/ont/fma/fma63261
T49 30662-30666 Body_part denotes Cell http://purl.org/sig/ont/fma/fma68646
T50 30722-30726 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T51 30757-30761 Body_part denotes Cell http://purl.org/sig/ont/fma/fma68646
T52 30782-30800 Body_part denotes type 2 pneumocytes http://purl.org/sig/ont/fma/fma62501
T53 30814-30819 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T54 31444-31449 Body_part denotes Serum http://purl.org/sig/ont/fma/fma63083
T55 31475-31480 Body_part denotes Serum http://purl.org/sig/ont/fma/fma63083

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 1254-1259 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T2 1685-1689 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T3 9057-9067 Body_part denotes epithelium http://purl.obolibrary.org/obo/UBERON_0000483
T4 9124-9128 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T5 9366-9373 Body_part denotes bronchi http://purl.obolibrary.org/obo/UBERON_0002185
T6 9414-9418 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T7 9419-9425 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T8 9517-9521 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T9 9588-9592 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T10 10370-10375 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T11 10819-10824 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T12 10848-10854 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311
T13 11144-11149 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T14 13374-13379 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T15 13411-13417 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311
T16 14130-14135 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T17 15256-15261 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T18 18467-18474 Body_part denotes trachea http://purl.obolibrary.org/obo/UBERON_0003126
T19 21837-21843 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T20 22060-22066 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T21 22745-22751 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T22 22752-22756 Body_part denotes Lung http://purl.obolibrary.org/obo/UBERON_0002048
T23 22862-22868 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T24 22952-22957 Body_part denotes Serum http://purl.obolibrary.org/obo/UBERON_0001977
T25 23069-23075 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311
T26 23181-23186 Body_part denotes Serum http://purl.obolibrary.org/obo/UBERON_0001977
T27 23354-23360 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311
T28 23520-23525 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T29 23637-23642 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T30 24072-24078 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311
T31 24304-24309 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T32 24544-24550 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311
T33 25202-25208 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311
T34 25769-25775 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T35 25860-25866 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311
T36 25981-25987 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311
T37 28519-28525 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T38 29497-29502 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T39 29997-30001 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T40 30251-30255 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T41 30722-30726 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T42 31444-31449 Body_part denotes Serum http://purl.obolibrary.org/obo/UBERON_0001977
T43 31475-31480 Body_part denotes Serum http://purl.obolibrary.org/obo/UBERON_0001977

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1 31-54 Disease denotes pulmonary aspergillosis MESH:D055732
5 143-175 Disease denotes Invasive pulmonary aspergillosis MESH:D055744
6 324-347 Disease denotes pulmonary aspergillosis MESH:D055732
7 389-413 Disease denotes invasive fungal diseases MESH:D000072742
16 1173-1186 Chemical denotes galactomannan MESH:C012990
17 919-939 Disease denotes respiratory distress MESH:D012128
18 1265-1286 Disease denotes pulmonary infiltrates MESH:D017254
19 1370-1387 Disease denotes tracheobronchitis
53 2834-2859 Disease denotes graft-versus-host disease MESH:D006086
20 1402-1423 Disease denotes pulmonary infiltrates MESH:D017254
21 1507-1515 Disease denotes COVID-19 MESH:C000657245
22 1527-1550 Disease denotes pulmonary aspergillosis MESH:D055732
23 1665-1684 Disease denotes SARS-CoV-2-infected MESH:C000657245
26 1913-1917 Chemical denotes CAPA
27 1865-1884 Disease denotes Aspergillus disease MESH:D001228
33 1938-1970 Disease denotes Invasive pulmonary aspergillosis MESH:D055744
34 1986-1998 Disease denotes co-infection MESH:D060085
35 2148-2171 Disease denotes pulmonary aspergillosis MESH:D055732
36 2259-2267 Disease denotes COVID-19 MESH:C000657245
37 2279-2302 Disease denotes pulmonary aspergillosis MESH:D055732
46 3028-3037 Chemical denotes ibrutinib MESH:C551803
47 2318-2350 Disease denotes Invasive pulmonary aspergillosis MESH:D055744
48 2431-2452 Disease denotes prolonged neutropenia MESH:D009503
49 2464-2502 Disease denotes neutrophil disorders or T cell defects MESH:C563515
50 2656-2678 Disease denotes invasive aspergillosis MESH:D055744
51 2736-2750 Disease denotes acute leukemia MESH:D015470
52 2752-2754 Disease denotes AL MESH:D009101
58 3355-3378 Disease denotes pulmonary aspergillosis MESH:D055732
59 3455-3461 Disease denotes Cancer MESH:D009369
60 3470-3477 Disease denotes Mycosis MESH:D015821
61 3817-3840 Disease denotes invasive fungal disease MESH:D000072742
67 4521-4525 Disease denotes CL-F OMIM:102510
68 4533-4552 Disease denotes infectious diseases MESH:D003141
69 4650-4652 Disease denotes PD MESH:D010300
70 4672-4674 Disease denotes LV MESH:C535509
71 4866-4890 Disease denotes invasive fungal diseases MESH:D000072742
79 8291-8304 Chemical denotes galactomannan MESH:C012990
80 8306-8308 Chemical denotes GM MESH:C012990
81 8680-8691 Chemical denotes oseltamivir MESH:D053139
82 8695-8704 Chemical denotes zanamivir MESH:D053243
83 6833-6842 Disease denotes mortality MESH:D003643
84 7343-7352 Disease denotes mortality MESH:D003643
85 8897-8901 Disease denotes COPD MESH:D029424
89 9725-9736 Chemical denotes oseltamivir MESH:D053139
90 9191-9210 Disease denotes Aspergillus disease MESH:D001228
91 9588-9599 Disease denotes lung damage MESH:D008171
98 10345-10347 Chemical denotes GM MESH:C012990
99 10376-10378 Chemical denotes GM MESH:C012990
100 10696-10698 Chemical denotes GM MESH:C012990
101 10825-10827 Chemical denotes GM MESH:C012990
102 10398-10409 Disease denotes neutropenic MESH:D009503
103 10621-10647 Disease denotes invasive tracheobronchitis MESH:D009361
113 10933-10946 Disease denotes invasive mold MESH:D009361
114 10969-10980 Disease denotes neutropenic MESH:D009503
115 11034-11048 Disease denotes critically ill MESH:D016638
116 11113-11142 Disease denotes Aspergillus tracheobronchitis MESH:D001228
117 11222-11267 Disease denotes airway-invasive Aspergillus tracheobronchitis MESH:D001228
118 11310-11316 Disease denotes ulcers MESH:D014456
119 11429-11450 Disease denotes pulmonary infiltrates MESH:D017254
120 11516-11520 Disease denotes ARDS MESH:D012128
121 11524-11543 Disease denotes bacterial infection MESH:D001424
124 12668-12673 Chemical denotes azole MESH:D001393
125 12756-12761 Chemical denotes azole MESH:D001393
131 13380-13382 Chemical denotes GM MESH:C012990
132 13527-13529 Chemical denotes GM MESH:C012990
133 13202-13223 Disease denotes pulmonary infiltrates MESH:D017254
134 13759-13776 Disease denotes tracheobronchitis
135 13998-14006 Disease denotes bleeding MESH:D006470
140 14136-14138 Chemical denotes GM MESH:C012990
141 14171-14173 Chemical denotes GM MESH:C012990
142 14304-14320 Disease denotes invasive disease MESH:D009361
143 14371-14387 Disease denotes invasive disease MESH:D009361
149 14806-14814 Chemical denotes steroids MESH:D013256
150 15227-15229 Chemical denotes GM MESH:C012990
151 15262-15272 Chemical denotes β-D-glucan
152 14905-14909 Disease denotes COPD MESH:D029424
153 14948-14954 Disease denotes sepsis MESH:D018805
160 15397-15401 Chemical denotes IAPA
161 15680-15692 Chemical denotes Posaconazole MESH:C101425
162 15439-15448 Disease denotes pneumonia MESH:D011014
163 15743-15758 Disease denotes neutropenic AML MESH:D015470
164 15783-15808 Disease denotes graft-versus-host disease MESH:D006086
165 16099-16112 Disease denotes malabsorption MESH:D008286
181 16337-16349 Chemical denotes voriconazole MESH:D065819
182 16354-16367 Chemical denotes isavuconazole MESH:C508735
183 16400-16413 Chemical denotes echinocandins MESH:D054714
184 16444-16450 Chemical denotes azoles MESH:D001393
185 16466-16480 Chemical denotes amphotericin B MESH:D000666
186 16482-16487 Chemical denotes L-AmB MESH:C068538
187 16519-16524 Chemical denotes azole MESH:D001393
188 16577-16582 Chemical denotes L-AmB MESH:C068538
189 16759-16764 Chemical denotes L-AmB MESH:C068538
190 16838-16844 Chemical denotes azoles MESH:D001393
191 16991-17003 Chemical denotes voriconazole MESH:D065819
192 17097-17109 Chemical denotes voriconazole MESH:D065819
193 17454-17467 Chemical denotes isavuconazole MESH:C508735
194 17066-17074 Disease denotes toxicity MESH:D064420
195 17305-17320 Disease denotes (neuro)toxicity MESH:C536203
201 17876-17888 Chemical denotes voriconazole MESH:D065819
202 17973-17987 Chemical denotes flucloxacillin MESH:D005436
203 18109-18115 Chemical denotes azoles MESH:D001393
204 18151-18157 Chemical denotes azoles MESH:D001393
205 17809-17822 Disease denotes co-infections MESH:D060085
208 18754-18760 Chemical denotes azoles MESH:D001393
209 18346-18375 Disease denotes Aspergillus tracheobronchitis MESH:D001228
211 20254-20274 Disease denotes respiratory distress MESH:D012128
214 21287-21294 Chemical denotes steroid MESH:D013256
215 20773-20796 Disease denotes invasive fungal disease MESH:D000072742
219 22486-22515 Disease denotes Aspergillus tracheobronchitis MESH:D001228
220 22552-22581 Disease denotes Aspergillus tracheobronchitis MESH:D001228
221 22650-22655 Disease denotes ulcer MESH:D014456
225 21846-21863 Disease denotes Tracheobronchitis
226 21891-21902 Disease denotes ulcerations MESH:D014456
227 22129-22146 Disease denotes tracheobronchitis
233 23526-23528 Chemical denotes GM MESH:C012990
234 23530-23532 Chemical denotes GM MESH:C012990
235 23612-23633 Disease denotes pulmonary infiltrates MESH:D017254
236 23704-23721 Disease denotes tracheobronchitis
237 23750-23767 Disease denotes tracheobronchitis
242 23880-23882 Chemical denotes GM MESH:C012990
243 24317-24319 Chemical denotes GM MESH:C012990
244 23842-23863 Disease denotes pulmonary infiltrates MESH:D017254
245 24010-24029 Disease denotes bacterial pneumonia MESH:D016920
250 25892-25894 Chemical denotes GM MESH:C012990
251 25958-25960 Chemical denotes GM MESH:C012990
252 26012-26014 Chemical denotes GM MESH:C012990
253 26104-26121 Disease denotes tracheobronchitis
260 26658-26660 Chemical denotes GM MESH:C012990
261 27116-27118 Chemical denotes GM MESH:C012990
262 26258-26267 Disease denotes infection MESH:D007239
263 26500-26538 Disease denotes invasive Aspergillus tracheobronchitis MESH:D001228
264 26941-26967 Disease denotes invasive tracheobronchitis MESH:D009361
265 27092-27101 Disease denotes infection MESH:D007239
268 27713-27721 Disease denotes COVID-19 MESH:C000657245
269 27733-27756 Disease denotes pulmonary aspergillosis MESH:D055732
282 30494-30512 Disease denotes SARS-2003-infected MESH:D045169
283 30532-30564 Disease denotes corticosteroids [61] Lymphopenia MESH:D008231
284 31028-31083 Disease denotes Fungal infection Invasive Aspergillus tracheobronchitis MESH:D000072742
285 31115-31153 Disease denotes Invasive Aspergillus tracheobronchitis MESH:D001228
286 31510-31518 Disease denotes COVID-19 MESH:C000657245
287 31537-31557 Disease denotes Secondary infections MESH:D060085
288 31741-31750 Disease denotes mortality MESH:D003643
289 31863-31871 Disease denotes COVID-19 MESH:C000657245
290 31910-31919 Disease denotes mortality MESH:D003643
291 31933-31941 Disease denotes COVID-19 MESH:C000657245
292 32029-32038 Disease denotes mortality MESH:D003643
293 32049-32057 Disease denotes COVID-19 MESH:C000657245
316 28698-28709 Chemical denotes oseltamivir MESH:D053139
317 28949-28953 Chemical denotes IAPA
318 29503-29514 Chemical denotes GM negative
319 27789-27813 Disease denotes coronavirus disease 2019 MESH:C000657245
320 27815-27823 Disease denotes COVID-19 MESH:C000657245
321 27916-27924 Disease denotes COVID-19 MESH:C000657245
322 27936-27959 Disease denotes pulmonary aspergillosis MESH:D055732
323 28135-28143 Disease denotes COVID-19 MESH:C000657245
324 28259-28267 Disease denotes COVID-19 MESH:C000657245
325 28342-28362 Disease denotes SARS-CoV-2 infection MESH:C000657245
326 28714-28734 Disease denotes SARS-CoV-2 infection MESH:C000657245
327 28875-28913 Disease denotes invasive Aspergillus tracheobronchitis MESH:D001228
328 29021-29025 Disease denotes SARS MESH:D045169
329 29057-29066 Disease denotes infection MESH:D007239
330 29143-29153 Disease denotes infections MESH:D007239
331 29361-29370 Disease denotes mortality MESH:D003643
332 29387-29395 Disease denotes COVID-19 MESH:C000657245
333 29540-29548 Disease denotes COVID-19 MESH:C000657245
334 29566-29582 Disease denotes invasive disease MESH:D009361
335 29646-29654 Disease denotes COVID-19 MESH:C000657245
336 29900-29908 Disease denotes COVID-19 MESH:C000657245
337 30231-30250 Disease denotes SARS-CoV-2-infected MESH:C000657245
340 35841-35862 Disease denotes Stepstone Pharma GmbH
341 38290-38308 Disease denotes FL van de Veerdonk MESH:C536528

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 10-19 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T2 41-54 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T3 162-175 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T4 218-227 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T5 303-312 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T6 334-347 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T7 956-965 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T8 1370-1387 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T9 1507-1515 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T10 1537-1550 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T11 1552-1556 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T12 1665-1673 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T13 1913-1917 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T14 1957-1970 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T15 1989-1998 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T16 2016-2025 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T17 2127-2136 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T18 2158-2171 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T19 2259-2267 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T20 2289-2302 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T21 2337-2350 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T22 2441-2452 Disease denotes neutropenia http://purl.obolibrary.org/obo/MONDO_0001475
T23 2656-2678 Disease denotes invasive aspergillosis http://purl.obolibrary.org/obo/MONDO_0000240
T24 2665-2678 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T25 2680-2682 Disease denotes IA http://purl.obolibrary.org/obo/MONDO_0000240
T26 2736-2750 Disease denotes acute leukemia http://purl.obolibrary.org/obo/MONDO_0010643
T27 2742-2750 Disease denotes leukemia http://purl.obolibrary.org/obo/MONDO_0005059
T28 2752-2754 Disease denotes AL http://purl.obolibrary.org/obo/MONDO_0010643
T29 2834-2859 Disease denotes graft-versus-host disease http://purl.obolibrary.org/obo/MONDO_0013730
T30 3097-3106 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T31 3292-3301 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T32 3334-3343 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T33 3365-3378 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T34 3455-3461 Disease denotes Cancer http://purl.obolibrary.org/obo/MONDO_0004992
T35 3470-3477 Disease denotes Mycosis http://purl.obolibrary.org/obo/MONDO_0002041
T36 4533-4543 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T37 6604-6613 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T38 6729-6738 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T39 6868-6877 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T40 7008-7032 Disease denotes Streptococcus pneumoniae http://purl.obolibrary.org/obo/MONDO_0005972
T41 7125-7134 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T42 7176-7185 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T43 7415-7424 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T44 7555-7564 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T45 7651-7660 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T46 7667-7676 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T47 7716-7725 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T48 8538-8547 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T49 8634-8643 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T50 8738-8747 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T51 8897-8901 Disease denotes COPD http://purl.obolibrary.org/obo/MONDO_0005002
T52 9071-9080 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T53 9136-9145 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T54 9988-9997 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T55 10252-10261 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T56 10630-10647 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T57 10893-10900 Disease denotes sterile http://purl.obolibrary.org/obo/MONDO_0005047
T58 11125-11142 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T59 11250-11267 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T60 11310-11316 Disease denotes ulcers http://purl.obolibrary.org/obo/MONDO_0043839
T61 11468-11477 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T62 11516-11520 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T63 11524-11543 Disease denotes bacterial infection http://purl.obolibrary.org/obo/MONDO_0005113
T64 11534-11543 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T65 11755-11764 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T66 12428-12437 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T67 13187-13196 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T68 13759-13776 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T69 13806-13816 Disease denotes ulceration http://purl.obolibrary.org/obo/MONDO_0043839
T70 14163-14165 Disease denotes IA http://purl.obolibrary.org/obo/MONDO_0000240
T71 14468-14477 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T72 14656-14665 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T73 14905-14909 Disease denotes COPD http://purl.obolibrary.org/obo/MONDO_0005002
T74 15429-15438 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T75 15439-15448 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T76 15660-15662 Disease denotes IA http://purl.obolibrary.org/obo/MONDO_0000240
T77 15737-15739 Disease denotes IA http://purl.obolibrary.org/obo/MONDO_0000240
T78 15755-15758 Disease denotes AML http://purl.obolibrary.org/obo/MONDO_0018874
T79 15783-15808 Disease denotes graft-versus-host disease http://purl.obolibrary.org/obo/MONDO_0013730
T80 16099-16112 Disease denotes malabsorption http://purl.obolibrary.org/obo/MONDO_0020598
T81 17208-17210 Disease denotes IA http://purl.obolibrary.org/obo/MONDO_0000240
T82 17812-17822 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T83 18358-18375 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T84 19656-19665 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T85 19734-19743 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T86 19949-19958 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T87 20018-20027 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T88 20291-20300 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T89 21072-21081 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T90 21846-21863 Disease denotes Tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T91 21891-21902 Disease denotes ulcerations http://purl.obolibrary.org/obo/MONDO_0043839
T92 22129-22146 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T93 22401-22410 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T94 22435-22444 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T95 22498-22515 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T96 22564-22581 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T97 22650-22655 Disease denotes ulcer http://purl.obolibrary.org/obo/MONDO_0043839
T98 22911-22916 Disease denotes ulcer http://purl.obolibrary.org/obo/MONDO_0043839
T99 23704-23721 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T100 23750-23767 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T101 24010-24029 Disease denotes bacterial pneumonia http://purl.obolibrary.org/obo/MONDO_0004652
T102 24020-24029 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T103 26104-26121 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T104 26200-26209 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T105 26258-26267 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T106 26521-26538 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T107 26740-26749 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T108 26838-26847 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T109 26882-26891 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T110 26950-26967 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T111 27092-27101 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T112 27713-27721 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T113 27743-27756 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T114 27789-27813 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T115 27815-27823 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T116 27916-27924 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T117 27946-27959 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T118 27961-27965 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T119 27999-28003 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T120 28089-28093 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T121 28135-28143 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T122 28259-28267 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T123 28342-28350 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T124 28353-28362 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T125 28377-28386 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T126 28401-28410 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T127 28543-28552 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T128 28714-28722 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T129 28725-28734 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T130 28896-28913 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T131 28930-28934 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T132 29021-29029 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T133 29051-29066 Disease denotes virus infection http://purl.obolibrary.org/obo/MONDO_0005108
T134 29057-29066 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T135 29143-29153 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T136 29240-29244 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T137 29277-29281 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T138 29387-29395 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T139 29465-29469 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T140 29540-29548 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T141 29646-29654 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T142 29900-29908 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T143 30092-30096 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T144 30231-30239 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T145 30312-30316 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T146 30329-30333 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T147 30494-30498 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T148 30553-30564 Disease denotes Lymphopenia http://purl.obolibrary.org/obo/MONDO_0003783
T149 31028-31044 Disease denotes Fungal infection http://purl.obolibrary.org/obo/MONDO_0002041
T150 31035-31044 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T151 31066-31083 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T152 31136-31153 Disease denotes tracheobronchitis http://purl.obolibrary.org/obo/MONDO_0021925
T153 31286-31290 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T154 31510-31518 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T155 31547-31560 Disease denotes infections In http://purl.obolibrary.org/obo/MONDO_0005550
T156 31620-31630 Disease denotes pneumoniae http://purl.obolibrary.org/obo/MONDO_0005249
T157 31784-31793 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T158 31831-31835 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T159 31863-31871 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T160 31880-31884 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T161 31933-31941 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T162 31950-31954 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T163 32049-32057 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T164 33115-33118 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T165 33300-33303 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T166 33364-33367 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T167 33404-33407 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T168 33431-33434 Disease denotes BMS http://purl.obolibrary.org/obo/MONDO_0006687
T169 33469-33472 Disease denotes BMS http://purl.obolibrary.org/obo/MONDO_0006687
T170 33482-33485 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T171 33509-33511 Disease denotes he http://purl.obolibrary.org/obo/MONDO_0017319
T172 33541-33544 Disease denotes BMS http://purl.obolibrary.org/obo/MONDO_0006687
T173 33554-33557 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T174 34006-34009 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T175 34322-34325 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T176 34471-34474 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T177 34504-34507 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T178 34647-34650 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T179 35603-35606 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T180 35895-35898 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T181 36069-36072 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T182 36143-36146 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T183 36177-36180 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T184 36295-36298 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T185 36516-36519 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T186 36578-36581 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T187 36703-36706 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T188 37759-37762 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T189 37971-37974 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T190 38210-38213 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088
T191 38257-38260 Disease denotes MSD http://purl.obolibrary.org/obo/MONDO_0010088

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 88-89 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T2 414-417 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T3 444-447 http://purl.obolibrary.org/obo/PR_000001343 denotes aim
T4 536-537 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T5 667-668 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 701-702 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T7 769-770 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T8 881-882 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 945-946 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T10 966-970 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T11 1290-1291 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T12 1685-1689 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T13 1685-1689 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T14 1703-1704 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T15 2360-2361 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T16 2488-2494 http://purl.obolibrary.org/obo/CL_0000084 denotes T cell
T17 2784-2788 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T18 3039-3043 http://purl.obolibrary.org/obo/CLO_0053799 denotes 4, 5
T19 3082-3083 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T20 3115-3118 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T21 3412-3424 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T22 3564-3565 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T23 3845-3846 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T24 4050-4052 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T25 4469-4475 http://purl.obolibrary.org/obo/UBERON_0007688 denotes fields
T26 4521-4523 http://purl.obolibrary.org/obo/CLO_0052906 denotes CL
T27 4560-4562 http://purl.obolibrary.org/obo/PR_000010213 denotes MB
T28 4598-4600 http://purl.obolibrary.org/obo/CLO_0007706 denotes MH
T29 4661-4663 http://purl.obolibrary.org/obo/UBERON_0003064 denotes IM
T30 4710-4712 http://purl.obolibrary.org/obo/CLO_0008828 denotes RL
T31 4759-4761 http://purl.obolibrary.org/obo/CLO_0007029 denotes JM
T32 4759-4761 http://purl.obolibrary.org/obo/CLO_0050993 denotes JM
T33 5025-5026 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T34 5067-5068 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T35 5132-5137 http://purl.obolibrary.org/obo/UBERON_0007688 denotes field
T36 5252-5253 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T37 5525-5526 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T38 5842-5844 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T39 5847-5848 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T40 5941-5942 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T41 6134-6135 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T42 6224-6225 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T43 6245-6254 http://purl.obolibrary.org/obo/OBI_0000245 denotes organizer
T44 6979-6981 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T45 7073-7074 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T46 7565-7566 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T47 7661-7662 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T48 7677-7678 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T49 7679-7686 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T50 7789-7791 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T51 8031-8033 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T52 8262-8267 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T53 8402-8403 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T54 8706-8708 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T55 9057-9067 http://purl.obolibrary.org/obo/UBERON_0000483 denotes epithelium
T56 9124-9128 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T57 9124-9128 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T58 9334-9339 http://purl.obolibrary.org/obo/UBERON_0000033 denotes heads
T59 9334-9339 http://www.ebi.ac.uk/efo/EFO_0000964 denotes heads
T60 9414-9418 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T61 9414-9418 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T62 9459-9460 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T63 9517-9521 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T64 9517-9521 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T65 9588-9592 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T66 9588-9592 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T67 9955-9956 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T68 11144-11149 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T69 11222-11228 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airway
T70 11271-11281 http://purl.obolibrary.org/obo/CL_0000066 denotes epithelial
T71 11556-11557 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T72 11925-11930 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T73 12181-12183 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T74 12208-12212 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T75 12306-12311 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T76 12522-12529 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T77 12568-12572 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T78 12685-12692 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T79 12780-12782 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T80 12881-12883 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T81 13146-13147 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T82 13183-13186 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T83 13383-13390 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T84 13494-13501 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airways
T85 13530-13537 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T86 13573-13583 http://purl.obolibrary.org/obo/UBERON_0000473 denotes Testing is
T87 13877-13879 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T88 14047-14048 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T89 14119-14120 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T90 14219-14231 http://purl.obolibrary.org/obo/UBERON_0001155 denotes colonization
T91 14287-14299 http://purl.obolibrary.org/obo/UBERON_0001155 denotes colonization
T92 14400-14402 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T93 14558-14559 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T94 14686-14687 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T95 14874-14875 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T96 15273-15277 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T97 15323-15325 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T98 15608-15614 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T99 15872-15875 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T100 16078-16079 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T101 16185-16186 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T102 16369-16371 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T103 16479-16480 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T104 16482-16487 http://purl.obolibrary.org/obo/NCBITaxon_9940 denotes L-AmB
T105 16535-16536 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T106 16577-16582 http://purl.obolibrary.org/obo/NCBITaxon_9940 denotes L-AmB
T107 16759-16764 http://purl.obolibrary.org/obo/NCBITaxon_9940 denotes L-AmB
T108 16934-16936 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T109 17010-17011 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T110 17083-17089 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T111 17216-17217 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T112 17445-17447 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T113 17495-17501 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T114 17587-17588 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T115 17721-17722 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T116 17918-17920 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T117 18214-18216 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T118 18259-18260 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T119 18417-18419 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T120 18887-18888 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T121 19427-19432 http://purl.obolibrary.org/obo/CLO_0009985 denotes focus
T122 19625-19626 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T123 19647-19651 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T124 19698-19699 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T125 19920-19926 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T126 19941-19942 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T127 19967-19971 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T128 19989-19995 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T129 20055-20056 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T130 20075-20076 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T131 20216-20217 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T132 20280-20281 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T133 20316-20320 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T134 20457-20459 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T135 20517-20518 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T136 20549-20550 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T137 20578-20582 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T138 20616-20623 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test is
T139 20923-20926 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T140 20927-20928 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T141 21639-21640 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T142 22030-22031 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T143 22058-22059 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T144 22110-22111 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T145 22617-22623 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airway
T146 22752-22756 http://purl.obolibrary.org/obo/UBERON_0002048 denotes Lung
T147 22752-22756 http://www.ebi.ac.uk/efo/EFO_0000934 denotes Lung
T148 22878-22884 http://purl.obolibrary.org/obo/UBERON_0001005 denotes Airway
T149 23122-23123 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T150 23251-23252 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T151 23407-23408 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T152 23509-23510 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T153 23637-23642 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T154 23865-23866 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T155 23897-23898 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T156 23966-23967 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T157 24070-24071 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T158 24100-24101 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T159 24213-24214 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T160 24244-24250 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airway
T161 24533-24534 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T162 24603-24604 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T163 24738-24739 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T164 24970-24971 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T165 25143-25144 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T166 25158-25164 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airway
T167 25212-25213 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T168 25281-25282 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T169 25533-25534 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T170 25849-25850 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T171 25947-25948 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T172 25961-25969 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test, as
T173 25970-25971 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T174 26001-26002 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T175 26046-26047 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T176 26082-26083 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T177 26094-26100 http://purl.obolibrary.org/obo/UBERON_0002553 denotes cavity
T178 26160-26163 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T179 26175-26176 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T180 26601-26608 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airways
T181 26617-26618 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T182 26716-26721 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T183 26892-26897 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T184 27299-27300 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T185 28108-28110 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T186 28226-28227 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T187 28288-28289 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T188 28768-28773 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T189 28783-28794 http://purl.obolibrary.org/obo/CLO_0053065 denotes human cells
T190 28838-28845 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airways
T191 29051-29056 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T192 29214-29217 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T193 29302-29303 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T194 29359-29360 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T195 29598-29607 http://purl.obolibrary.org/obo/UBERON_0001155 denotes colonized
T196 29672-29673 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T197 29997-30001 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T198 29997-30001 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T199 30251-30255 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T200 30251-30255 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T201 30589-30597 http://purl.obolibrary.org/obo/CL_0000576 denotes monocyte
T202 30656-30661 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes Virus
T203 30662-30666 http://purl.obolibrary.org/obo/GO_0005623 denotes Cell
T204 30702-30712 http://purl.obolibrary.org/obo/CL_0000066 denotes epithelial
T205 30722-30726 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T206 30722-30726 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T207 30744-30751 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airways
T208 30757-30761 http://purl.obolibrary.org/obo/GO_0005623 denotes Cell
T209 30814-30819 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T210 30991-30994 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T211 31751-31753 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T212 32240-32243 http://purl.obolibrary.org/obo/CL_0000990 denotes CDC
T213 32426-32435 http://purl.obolibrary.org/obo/OBI_0000245 denotes organized
T214 32590-32592 http://purl.obolibrary.org/obo/CLO_0007029 denotes JM
T215 32590-32592 http://purl.obolibrary.org/obo/CLO_0050993 denotes JM
T216 32619-32620 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T217 32812-32813 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T218 33319-33322 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T219 33606-33607 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T220 33724-33727 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T221 33954-33957 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T222 34129-34132 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T223 34817-34820 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T224 35267-35270 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T225 35441-35443 http://www.ebi.ac.uk/efo/EFO_0000265 denotes Da
T226 35954-35956 http://purl.obolibrary.org/obo/CLO_0001980 denotes BJ
T227 35966-35969 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T228 35975-35976 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T229 36370-36373 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T230 36415-36418 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T231 36482-36485 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T232 36533-36536 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T233 36658-36661 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T234 36740-36741 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T235 37072-37074 http://purl.obolibrary.org/obo/CLO_0007706 denotes MH
T236 37082-37085 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T237 37520-37523 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T238 37696-37699 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T239 37767-37770 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T240 37892-37895 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T241 38007-38010 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T242 38139-38140 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T243 38290-38292 http://purl.obolibrary.org/obo/CLO_0003358 denotes FL
T244 38309-38312 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 538-543 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T2 1173-1186 Chemical denotes galactomannan http://purl.obolibrary.org/obo/CHEBI_27680
T3 1246-1249 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T4 2352-2355 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T6 2680-2682 Chemical denotes IA http://purl.obolibrary.org/obo/CHEBI_74062
T7 2752-2754 Chemical denotes AL http://purl.obolibrary.org/obo/CHEBI_73770
T8 2870-2880 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T9 3028-3037 Chemical denotes ibrutinib http://purl.obolibrary.org/obo/CHEBI_76612
T10 3111-3114 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T12 3245-3248 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T14 3629-3632 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T16 4021-4024 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T18 4517-4519 Chemical denotes KL http://purl.obolibrary.org/obo/CHEBI_74561
T19 4598-4600 Chemical denotes MH http://purl.obolibrary.org/obo/CHEBI_74703
T20 4632-4640 Chemical denotes medicine http://purl.obolibrary.org/obo/CHEBI_23888
T21 4642-4644 Chemical denotes EA http://purl.obolibrary.org/obo/CHEBI_73849
T22 4650-4652 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T23 4654-4656 Chemical denotes PW http://purl.obolibrary.org/obo/CHEBI_74797
T24 4657-4659 Chemical denotes LL http://purl.obolibrary.org/obo/CHEBI_73531
T25 4661-4663 Chemical denotes IM http://purl.obolibrary.org/obo/CHEBI_74073
T26 4672-4674 Chemical denotes LV http://purl.obolibrary.org/obo/CHEBI_73579
T27 4710-4712 Chemical denotes RL http://purl.obolibrary.org/obo/CHEBI_73815
T28 4759-4761 Chemical denotes JM http://purl.obolibrary.org/obo/CHEBI_31739
T29 5254-5259 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T30 5312-5317 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T31 5445-5450 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T32 7219-7222 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T34 8151-8166 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T35 8291-8304 Chemical denotes galactomannan http://purl.obolibrary.org/obo/CHEBI_27680
T36 8306-8308 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T38 8644-8653 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T39 8680-8691 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T40 8695-8704 Chemical denotes zanamivir http://purl.obolibrary.org/obo/CHEBI_50663
T41 9668-9683 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T42 9691-9715 Chemical denotes neuraminidase inhibitors http://purl.obolibrary.org/obo/CHEBI_52425
T43 9705-9715 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T44 9725-9736 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T45 9845-9855 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T46 10341-10344 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T47 10345-10347 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T49 10376-10378 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T51 10469-10472 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T52 10692-10695 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T53 10696-10698 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T55 10761-10764 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T56 10825-10827 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T58 11568-11581 Chemical denotes antimicrobial http://purl.obolibrary.org/obo/CHEBI_33281
T59 11673-11683 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T60 11875-11885 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T61 11995-11998 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T63 12049-12051 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T65 12494-12497 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T66 12514-12521 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T67 12624-12627 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T68 12668-12673 Chemical denotes azole http://purl.obolibrary.org/obo/CHEBI_68452
T69 12756-12761 Chemical denotes azole http://purl.obolibrary.org/obo/CHEBI_68452
T70 12852-12862 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T71 12982-12992 Chemical denotes antivirals http://purl.obolibrary.org/obo/CHEBI_22587
T72 13012-13023 Chemical denotes antibiotics http://purl.obolibrary.org/obo/CHEBI_33281
T73 13043-13057 Chemical denotes corticosteroid http://purl.obolibrary.org/obo/CHEBI_50858
T74 13380-13382 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T76 13513-13516 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T77 13527-13529 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T79 13872-13875 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T81 14136-14138 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T83 14163-14165 Chemical denotes IA http://purl.obolibrary.org/obo/CHEBI_74062
T84 14167-14170 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T85 14171-14173 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T87 14413-14428 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T88 14623-14638 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T89 14806-14814 Chemical denotes steroids http://purl.obolibrary.org/obo/CHEBI_35341
T90 15126-15141 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T91 15163-15178 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T92 15227-15229 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T94 15243-15246 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T95 15266-15272 Chemical denotes glucan http://purl.obolibrary.org/obo/CHEBI_37163
T96 15343-15353 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T97 15453-15463 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T98 15615-15631 Chemical denotes antifungal agent http://purl.obolibrary.org/obo/CHEBI_35718
T99 15660-15662 Chemical denotes IA http://purl.obolibrary.org/obo/CHEBI_74062
T100 15737-15739 Chemical denotes IA http://purl.obolibrary.org/obo/CHEBI_74062
T101 15972-15974 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T102 16139-16141 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T103 16325-16328 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T105 16337-16349 Chemical denotes voriconazole http://purl.obolibrary.org/obo/CHEBI_10023
T106 16354-16367 Chemical denotes isavuconazole http://purl.obolibrary.org/obo/CHEBI_85979
T107 16400-16413 Chemical denotes echinocandins http://purl.obolibrary.org/obo/CHEBI_57248
T108 16444-16450 Chemical denotes azoles http://purl.obolibrary.org/obo/CHEBI_68452
T109 16466-16480 Chemical denotes amphotericin B http://purl.obolibrary.org/obo/CHEBI_2682
T110 16519-16524 Chemical denotes azole http://purl.obolibrary.org/obo/CHEBI_68452
T111 16640-16644 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T112 16773-16786 Chemical denotes echinocandins http://purl.obolibrary.org/obo/CHEBI_57248
T113 16788-16792 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T114 16838-16844 Chemical denotes azoles http://purl.obolibrary.org/obo/CHEBI_68452
T115 16907-16911 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T116 16965-16969 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T117 16991-17003 Chemical denotes voriconazole http://purl.obolibrary.org/obo/CHEBI_10023
T118 17097-17109 Chemical denotes voriconazole http://purl.obolibrary.org/obo/CHEBI_10023
T119 17208-17210 Chemical denotes IA http://purl.obolibrary.org/obo/CHEBI_74062
T120 17454-17467 Chemical denotes isavuconazole http://purl.obolibrary.org/obo/CHEBI_85979
T121 17657-17667 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T122 17732-17736 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T123 17737-17741 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T124 17876-17888 Chemical denotes voriconazole http://purl.obolibrary.org/obo/CHEBI_10023
T125 17973-17987 Chemical denotes flucloxacillin http://purl.obolibrary.org/obo/CHEBI_5098
T126 18109-18115 Chemical denotes azoles http://purl.obolibrary.org/obo/CHEBI_68452
T127 18128-18132 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T128 18151-18157 Chemical denotes azoles http://purl.obolibrary.org/obo/CHEBI_68452
T129 18162-18167 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T130 18231-18241 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T131 18299-18309 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T132 18570-18581 Chemical denotes antifungals http://purl.obolibrary.org/obo/CHEBI_35718
T133 18703-18714 Chemical denotes antifungals http://purl.obolibrary.org/obo/CHEBI_35718
T134 18754-18760 Chemical denotes azoles http://purl.obolibrary.org/obo/CHEBI_68452
T135 18785-18793 Chemical denotes polyenes http://purl.obolibrary.org/obo/CHEBI_48121
T136 18929-18939 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T137 19003-19018 Chemical denotes antifungal drug http://purl.obolibrary.org/obo/CHEBI_35718|http://purl.obolibrary.org/obo/CHEBI_86327
T139 19014-19018 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T140 19042-19055 Chemical denotes echinocandins http://purl.obolibrary.org/obo/CHEBI_57248
T141 19149-19159 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T142 19203-19207 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T143 19959-19966 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T144 20308-20315 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T145 20917-20922 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T146 21287-21294 Chemical denotes steroid http://purl.obolibrary.org/obo/CHEBI_35341
T147 22452-22459 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T148 22958-22960 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T150 22976-22979 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T151 22980-22982 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T153 23007-23010 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T154 23187-23189 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T156 23205-23208 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T157 23209-23211 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T159 23236-23239 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T160 23526-23528 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T162 23530-23532 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T164 23876-23879 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T165 23880-23882 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T167 24313-24316 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T168 24317-24319 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T170 24323-24326 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T171 25283-25286 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T172 25287-25289 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T174 25652-25655 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T176 25888-25891 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T177 25892-25894 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T179 25958-25960 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T181 26012-26014 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T183 26353-26356 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T185 26654-26657 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T186 26658-26660 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T188 27116-27118 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T190 27154-27157 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T191 27231-27236 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T192 27544-27554 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T193 27776-27779 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T195 28252-28255 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T197 28604-28609 Chemical denotes NADPH http://purl.obolibrary.org/obo/CHEBI_16474|http://purl.obolibrary.org/obo/CHEBI_57783
T199 28664-28688 Chemical denotes neuraminidase inhibitors http://purl.obolibrary.org/obo/CHEBI_52425
T200 28678-28688 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T201 28698-28709 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T202 29093-29096 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T204 29334-29344 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T205 29410-29413 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T207 29503-29505 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T209 29690-29693 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T211 29798-29813 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T212 30454-30468 Chemical denotes corticosteroid http://purl.obolibrary.org/obo/CHEBI_50858
T213 30477-30480 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T215 30532-30547 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T216 30681-30693 Chemical denotes sialic acids http://purl.obolibrary.org/obo/CHEBI_26667
T217 30688-30693 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T218 30865-30870 Chemical denotes NADPH http://purl.obolibrary.org/obo/CHEBI_16474|http://purl.obolibrary.org/obo/CHEBI_57783
T220 30941-30951 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T221 31337-31340 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T222 31341-31343 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T224 31368-31371 Chemical denotes BAL http://purl.obolibrary.org/obo/CHEBI_64198
T225 31372-31374 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T227 31450-31452 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T229 31481-31483 Chemical denotes GM http://purl.obolibrary.org/obo/CHEBI_74120|http://purl.obolibrary.org/obo/CHEBI_27680
T231 32586-32588 Chemical denotes KL http://purl.obolibrary.org/obo/CHEBI_74561
T232 32590-32592 Chemical denotes JM http://purl.obolibrary.org/obo/CHEBI_31739
T233 33066-33068 Chemical denotes PE http://purl.obolibrary.org/obo/CHEBI_16038|http://purl.obolibrary.org/obo/CHEBI_17553|http://purl.obolibrary.org/obo/CHEBI_74762
T236 34675-34677 Chemical denotes GE http://purl.obolibrary.org/obo/CHEBI_73801
T237 35153-35155 Chemical denotes OA http://purl.obolibrary.org/obo/CHEBI_138856
T238 35805-35807 Chemical denotes DR http://purl.obolibrary.org/obo/CHEBI_73445
T239 37072-37074 Chemical denotes MH http://purl.obolibrary.org/obo/CHEBI_74703
T240 37313-37315 Chemical denotes TF http://purl.obolibrary.org/obo/CHEBI_74862
T241 37510-37512 Chemical denotes TR http://purl.obolibrary.org/obo/CHEBI_74825
T242 38290-38292 Chemical denotes FL http://purl.obolibrary.org/obo/CHEBI_91150

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 4127-4139 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T2 5182-5194 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T3 5611-5619 http://purl.obolibrary.org/obo/GO_0015297 denotes exchange
T4 8922-8934 http://purl.obolibrary.org/obo/GO_0009405 denotes Pathogenesis
T5 8979-8991 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T6 9379-9394 http://purl.obolibrary.org/obo/GO_0044409 denotes invasive growth
T7 9379-9394 http://purl.obolibrary.org/obo/GO_0036267 denotes invasive growth
T8 9388-9394 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T9 9427-9438 http://purl.obolibrary.org/obo/GO_0043934 denotes Sporulation
T10 9427-9438 http://purl.obolibrary.org/obo/GO_0030437 denotes Sporulation
T11 10459-10465 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T12 22696-22702 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T13 22813-22819 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T14 28326-28338 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T15 29969-29975 http://purl.obolibrary.org/obo/GO_0040007 denotes growth

LitCovid-PD-GlycoEpitope

Id Subject Object Predicate Lexical cue glyco_epitope_db_id
T1 1173-1186 GlycoEpitope denotes galactomannan http://www.glycoepitope.jp/epitopes/EP0510
T2 8291-8304 GlycoEpitope denotes galactomannan http://www.glycoepitope.jp/epitopes/EP0510
T3 8306-8308 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T4 10345-10347 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T5 10376-10378 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T6 10696-10698 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T7 10825-10827 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T8 12049-12051 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T9 13380-13382 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T10 13527-13529 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T11 14136-14138 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T12 14171-14173 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T13 15227-15229 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T14 22958-22960 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T15 22980-22982 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T16 23187-23189 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T17 23209-23211 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T18 23526-23528 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T19 23530-23532 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T20 23880-23882 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T21 24317-24319 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T22 25287-25289 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T23 25892-25894 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T24 25958-25960 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T25 26012-26014 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T26 26658-26660 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T27 27116-27118 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T28 29503-29505 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T29 31341-31343 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T30 31372-31374 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T31 31450-31452 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510
T32 31481-31483 GlycoEpitope denotes GM http://www.glycoepitope.jp/epitopes/EP0510

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 143-175 Phenotype denotes Invasive pulmonary aspergillosis http://purl.obolibrary.org/obo/HP_0020103
T2 919-939 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T3 1265-1286 Phenotype denotes pulmonary infiltrates http://purl.obolibrary.org/obo/HP_0002113
T4 1402-1423 Phenotype denotes pulmonary infiltrates http://purl.obolibrary.org/obo/HP_0002113
T5 1938-1970 Phenotype denotes Invasive pulmonary aspergillosis http://purl.obolibrary.org/obo/HP_0020103
T6 2318-2350 Phenotype denotes Invasive pulmonary aspergillosis http://purl.obolibrary.org/obo/HP_0020103
T7 2352-2355 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T8 2441-2452 Phenotype denotes neutropenia http://purl.obolibrary.org/obo/HP_0001875
T9 2736-2750 Phenotype denotes acute leukemia http://purl.obolibrary.org/obo/HP_0002488
T10 2752-2754 Phenotype denotes AL http://purl.obolibrary.org/obo/HP_0002488
T11 3111-3114 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T12 3245-3248 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T13 3455-3461 Phenotype denotes Cancer http://purl.obolibrary.org/obo/HP_0002664
T14 3629-3632 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T15 4021-4024 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T16 7022-7032 Phenotype denotes pneumoniae http://purl.obolibrary.org/obo/HP_0002090
T17 7219-7222 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T18 8897-8901 Phenotype denotes COPD http://purl.obolibrary.org/obo/HP_0006510
T19 11429-11450 Phenotype denotes pulmonary infiltrates http://purl.obolibrary.org/obo/HP_0002113
T20 11995-11998 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T21 13202-13223 Phenotype denotes pulmonary infiltrates http://purl.obolibrary.org/obo/HP_0002113
T22 13872-13875 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T23 14905-14909 Phenotype denotes COPD http://purl.obolibrary.org/obo/HP_0006510
T24 14948-14954 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T25 15439-15448 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T26 15755-15758 Phenotype denotes AML http://purl.obolibrary.org/obo/HP_0004808
T27 16099-16112 Phenotype denotes malabsorption http://purl.obolibrary.org/obo/HP_0002024
T28 16325-16328 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T29 20254-20274 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T30 23125-23145 Phenotype denotes Pulmonary infiltrate http://purl.obolibrary.org/obo/HP_0002113
T31 23612-23633 Phenotype denotes pulmonary infiltrates http://purl.obolibrary.org/obo/HP_0002113
T32 23842-23863 Phenotype denotes pulmonary infiltrates http://purl.obolibrary.org/obo/HP_0002113
T33 24020-24029 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T34 25652-25655 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T35 26353-26356 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T36 27776-27779 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T37 28252-28255 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T38 29093-29096 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T39 29410-29413 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T40 29690-29693 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T41 30477-30480 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T42 30553-30564 Phenotype denotes Lymphopenia http://purl.obolibrary.org/obo/HP_0001888
T43 31620-31630 Phenotype denotes pneumoniae http://purl.obolibrary.org/obo/HP_0002090

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-124 Sentence denotes Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
T2 126-134 Sentence denotes Abstract
T3 135-142 Sentence denotes Purpose
T4 143-270 Sentence denotes Invasive pulmonary aspergillosis is increasingly reported in patients with influenza admitted to the intensive care unit (ICU).
T5 271-526 Sentence denotes Classification of patients with influenza-associated pulmonary aspergillosis (IAPA) using the current definitions for invasive fungal diseases has proven difficult, and our aim was to develop case definitions for IAPA that can facilitate clinical studies.
T6 528-535 Sentence denotes Methods
T7 536-733 Sentence denotes A group of 29 international experts reviewed current insights into the epidemiology, diagnosis and management of IAPA and proposed a case definition of IAPA through a process of informal consensus.
T8 735-742 Sentence denotes Results
T9 743-845 Sentence denotes Since IAPA may develop in a wide range of hosts, an entry criterion was proposed and not host factors.
T10 846-1007 Sentence denotes The entry criterion was defined as a patient requiring ICU admission for respiratory distress with a positive influenza test temporally related to ICU admission.
T11 1008-1132 Sentence denotes In addition, proven IAPA required histological evidence of invasive septate hyphae and mycological evidence for Aspergillus.
T12 1133-1440 Sentence denotes Probable IAPA required the detection of galactomannan or positive Aspergillus culture in bronchoalveolar lavage (BAL) or serum with pulmonary infiltrates or a positive culture in upper respiratory samples with bronchoscopic evidence for tracheobronchitis or cavitating pulmonary infiltrates of recent onset.
T13 1441-1690 Sentence denotes The IAPA case definitions may be useful to classify patients with COVID-19-associated pulmonary aspergillosis (CAPA), while awaiting further studies that provide more insight into the interaction between Aspergillus and the SARS-CoV-2-infected lung.
T14 1692-1702 Sentence denotes Conclusion
T15 1703-1918 Sentence denotes A consensus case definition of IAPA is proposed, which will facilitate research into the epidemiology, diagnosis and management of this emerging acute and severe Aspergillus disease, and may be of use to study CAPA.
T16 1920-1937 Sentence denotes Take-home message
T17 1938-2054 Sentence denotes Invasive pulmonary aspergillosis is an emerging co-infection in patients with influenza who are admitted to the ICU.
T18 2055-2303 Sentence denotes An international team of experts proposed consensus case definitions of influenza-associated pulmonary aspergillosis in order to facilitate clinical studies and the definition may also be useful to study COVID-19-associated pulmonary aspergillosis.
T19 2305-2317 Sentence denotes Introduction
T20 2318-2623 Sentence denotes Invasive pulmonary aspergillosis (IPA) is a well-recognized disease affecting immunocompromised individuals with prolonged neutropenia, inherited neutrophil disorders or T cell defects, with the risk depending on the patients’ underlying disease and the type and duration of immunosuppressive therapy [1].
T21 2624-2925 Sentence denotes Patients at the highest risk of invasive aspergillosis (IA) include those undergoing intensive chemotherapy for acute leukemia (AL) or recipients of allogeneic cell transplantation (alloHCT) who develop severe graft-versus-host disease, for whom antifungal prophylaxis is currently recommended [2, 3].
T22 2926-3045 Sentence denotes With changing treatment modalities, new risk groups continue to emerge, such as patients treated with ibrutinib [4, 5].
T23 3046-3308 Sentence denotes Although over the past four decades a link between influenza and IPA has been noted in single cases [6], recent cohort studies provide new insights into the epidemiology and clinical presentation of IPA in intensive care unit (ICU) patients with influenza [7–9].
T24 3309-3675 Sentence denotes Patients presenting with influenza-associated pulmonary aspergillosis (IAPA) may have classic European Organization for Research and Treatment of Cancer (EORTC)/Mycosis Study Group Education and Research Consortium (MSGERC)-defined host factors [10], but a notable proportion of patients was deemed to be at low risk of IPA, including previously healthy individuals.
T25 3676-3841 Sentence denotes In addition, the clinical and radiological presentation was often atypical with radiological features that were not considered suggestive of invasive fungal disease.
T26 3842-4054 Sentence denotes As a consequence, we cannot classify these patients according to existing consensus definitions, i.e., the EORTC/MSGERC definitions and the AspICU algorithm for classification of IPA patients in the ICU [10, 11].
T27 4055-4276 Sentence denotes We therefore set out to discuss current insights into the epidemiology, pathogenesis, diagnosis and management of IAPA and to propose case definitions that can facilitate homogeneity and comparability in clinical studies.
T28 4278-4302 Sentence denotes Participants and methods
T29 4303-4402 Sentence denotes The expert panel is comprised of 29 participants from seven European countries, the USA and Taiwan.
T30 4403-4763 Sentence denotes To ensure heterogenicity, participants were selected from various fields of expertise: medical microbiology (PEV, KL, CL-F, TRR), infectious diseases (BJAR, MB, TC, CJC, OAC, DRG, NAFJ, BJK, OL, MH-N, TFP, FLvdV), intensive care medicine (EA, SB, PD, PW-LL, IM-L, JAS, LV, JW), clinical pharmacology (RJMB, RL, IS), public health (TC) and hematology (OAC, JM).
T31 4764-4931 Sentence denotes Selected participants furthermore had specific expertise in epidemiology, diagnosis and management of invasive fungal diseases or fungal disease guideline development.
T32 4932-4984 Sentence denotes The meeting was prepared by PEV, RJMB, JW and FLvdV.
T33 4985-5057 Sentence denotes Case definitions were developed through a process of informal consensus.
T34 5058-5393 Sentence denotes Although a systematic literature review was not performed, experts in the field presented overviews regarding epidemiology, pathogenesis, diagnosis and treatment of IAPA, which were followed by a group discussion process designed to allow members of the group to voice their opinions and contribute equally to the decision-making [12].
T35 5394-5472 Sentence denotes The goal of the consensus process was to bring the group to general agreement.
T36 5473-5658 Sentence denotes Presentations and initial discussions took place on a single day meeting in April 2019 in Amsterdam and were continued through electronic exchange of views until consensus was achieved.
T37 5659-5846 Sentence denotes The chosen framework included host and risk factors, clinical factors and mycological evidence, similar to the framework in the EORTC/MSGERC definitions and the AspICU algorithm [10, 11].
T38 5847-5940 Sentence denotes A medical writer made notes of the meeting, which were used as input to write the manuscript.
T39 5941-6057 Sentence denotes A first draft manuscript was prepared by PEV, BJAR, RJMB, JW and FLvdV and circulated for comments from all experts.
T40 6058-6111 Sentence denotes The experts reviewed and commented on the manuscript.
T41 6112-6178 Sentence denotes Using these comments, a final version was circulated for approval.
T42 6179-6393 Sentence denotes The logistics of the meeting were handled by a certified Congress organizer (Congress Care, s’Hertogenbosch, the Netherlands) with financial support of Pfizer (Pfizer B.V., Capelle aan den IJssel, the Netherlands).
T43 6394-6564 Sentence denotes Congress Care and Pfizer had no influence on the selection of participants, selected topics, discussions, preparation and final approval of the content of the manuscript.
T44 6566-6579 Sentence denotes Expert review
T45 6581-6622 Sentence denotes Global epidemiology of influenza and IAPA
T46 6623-6828 Sentence denotes Although figures vary depending on geographic region, season and vaccination rates, approximately 0.1% of influenza patients require hospital admission with 5–10% of these requiring ICU admission [13, 14].
T47 6829-6929 Sentence denotes The mortality in patients admitted for influenza is 4% and 20–25% for those admitted to ICU [14–16].
T48 6930-7063 Sentence denotes Bacterial superinfection is common, affecting 10–35% of cases, typically with Streptococcus pneumoniae or Staphylococcus aureus [16].
T49 7064-7306 Sentence denotes However, a recent Dutch–Belgian multicenter study over seven influenza seasons in seven institutes demonstrated influenza as an independent risk factor of IPA (adjusted odds ratio 5.19, 95% confidence interval (CI) 2.63–10.26, p < 0.001) [9].
T50 7307-7505 Sentence denotes Results also showed that the 90-day mortality rate for ICU patients with IAPA was almost double that of ICU influenza patients without IAPA (51% vs. 28%, adjusted odds ratio 1.87, 95% CI 1.05–3.32).
T51 7506-7691 Sentence denotes IAPA was initially thought to be associated with influenza A/H1N1pdm09 only [7, 17], but it became clear that IAPA is also associated with other influenza A and influenza B viruses [9].
T52 7692-7793 Sentence denotes The median time between influenza diagnosis and IAPA was short, often in the first 5 days [7, 8, 18].
T53 7794-8035 Sentence denotes Studies have shown considerable variation in rates of IAPA in different countries, with high rates in the Netherlands, Belgium and Taiwan, but lower rates in other countries [19], and in some we do not know the incidence (e.g., USA) [20–22].
T54 8036-8356 Sentence denotes Potential reasons for these regional differences are related to the underlying conditions, concomitant exposure to corticosteroids, environmental factors, including exposure to Aspergillus, use of non-culture-based diagnostic tests for Aspergillus (e.g., galactomannan (GM)) and differences in awareness of IAPA [23–25].
T55 8357-8455 Sentence denotes Autopsy rates are very low, which results in a considerable underdiagnosis in many countries [26].
T56 8456-8710 Sentence denotes Other factors that might contribute to regional differences in IAPA rates include influenza vaccination rates, with different policies in different countries, and differences in influenza antiviral treatment strategies with oseltamivir or zanamivir [27].
T57 8711-8920 Sentence denotes Annual vaccination reduces influenza-associated complications (hospitalization, ICU admission, severity of illness, superinfection) and improves the outcome in transplant recipients and COPD patients [28, 29].
T58 8922-8942 Sentence denotes Pathogenesis of IAPA
T59 8943-9265 Sentence denotes In pending studies that explore the pathogenesis of IAPA and host immune defects, it is likely that damage to the epithelium by influenza and defective fungal host responses in the lung due to influenza and/or inflammatory conditions predispose to Aspergillus disease, similar as what is seen in bacterial superinfections.
T60 9266-9426 Sentence denotes Furthermore, autopsy studies have shown the presence of sporulating heads of Aspergillus inside the bronchi with invasive growth occurring into the lung tissue.
T61 9427-9600 Sentence denotes Sporulation could contribute to a high fungal burden and spread of the disease within the lung, thus contributing to the rapid disease progression and extensive lung damage.
T62 9601-9745 Sentence denotes Other factors that have been implicated in IAPA include the use of corticosteroids and of neuraminidase inhibitors, such as oseltamivir [7, 30].
T63 9746-9909 Sentence denotes Ultimately, these insights may aid in identifying patients at risk of IAPA and to design effective antifungal and adjunctive immunomodulatory treatment strategies.
T64 9911-9954 Sentence denotes Clinical presentation and diagnosis of IAPA
T65 9955-10105 Sentence denotes A retrospective Belgian study of influenza patients admitted to ICU between September 2009 and March 2011 showed that 9 of 40 (23%) patients had IAPA.
T66 10106-10227 Sentence denotes Four cases (44%) were proven despite not being immunocompromised according to the EORTC/MSGERC consensus definitions [7].
T67 10228-10309 Sentence denotes The median time between influenza diagnosis and IAPA was 2 days (range 0–4 days).
T68 10310-10410 Sentence denotes All IAPA patients had positive BAL GM, and 78% had positive serum GM, despite not being neutropenic.
T69 10411-10652 Sentence denotes Eighty-nine percent of patients had Aspergillus growth in BAL culture (almost exclusively Aspergillus fumigatus), and 55% of patients had endobronchial lesions observed during bronchoscopy, possibly indicating invasive tracheobronchitis [7].
T70 10653-10760 Sentence denotes Similar performance characteristics of BAL GM and culture were reported in two other cohort studies [8, 9].
T71 10761-10901 Sentence denotes BAL sampling is thus an important diagnostic procedure as serum GM can be negative and sputum/tracheal aspirate cultures can remain sterile.
T72 10902-11058 Sentence denotes Lesions that are suggestive of invasive mold disease on imaging in neutropenic patients, such as the halo sign, are often absent in critically ill patients.
T73 11059-11192 Sentence denotes However, in some IAPA patients with autopsy-confirmed Aspergillus tracheobronchitis, chest CT demonstrated peribronchial infiltrates.
T74 11193-11402 Sentence denotes The main diagnostic clue for airway-invasive Aspergillus tracheobronchitis is epithelial plaques, pseudomembranes or ulcers that can be visualized via bronchoscopy, as radiological features may be subtle [31].
T75 11403-11636 Sentence denotes Worsening of radiographic pulmonary infiltrates in patients with influenza is often attributed to progression of ARDS or bacterial infection, leading to a change of antimicrobial therapy without performing diagnostic procedures [32].
T76 11637-11911 Sentence denotes Patients who survived IAPA received antifungal therapy much earlier than those who did not (2 days after diagnosis of influenza among survivors versus 9 days among non-survivors) [8], suggesting that early diagnosis and administration of antifungal therapy may be important.
T77 11912-12120 Sentence denotes Lateral flow tests have recently become available as an alternative for diagnosing IPA (AspLFD, OLM Diagnostics and the sōna Aspergillus GM, IMMY) showing overall good performance in hematology patients [33].
T78 12121-12283 Sentence denotes The very quick assessment, with results available within 30–45 min, makes this type of test very attractive for the management of IAPA and use in clinical trials.
T79 12284-12362 Sentence denotes However, lateral flow tests have not yet been validated in the ICU population.
T80 12363-12554 Sentence denotes IAPA needs to be considered in patients admitted to the ICU with influenza and where indicated these patients should undergo early BAL for Aspergillus antigen testing, culture and microscopy.
T81 12555-12784 Sentence denotes Patients who test positive require anti-Aspergillus therapy, and the BAL fluid sample should be fast-tracked for azole resistance testing by PCR (and culture when positive) in regions with high (> 5%) azole resistance rates [34].
T82 12785-12903 Sentence denotes This would enable diagnostic assessment and initiation of adequate antifungal therapy within 24–48 h of ICU admission.
T83 12904-13083 Sentence denotes Diagnostic workup for IAPA may be repeated in patients deteriorating while on antivirals and/or appropriate antibiotics or when initiating corticosteroid treatment is unavoidable.
T84 13085-13142 Sentence denotes Discussion on clinical presentation and diagnosis of IAPA
T85 13143-13319 Sentence denotes If a patient is admitted to the ICU and has influenza with pulmonary infiltrates, the diagnosis of IAPA should be considered and further investigation performed as appropriate.
T86 13320-13572 Sentence denotes Ideally, this would include in order of invasiveness, serum GM testing, fungal cultures of sputum and/or tracheal aspirate, pulmonary CT, bronchoscopy to visualize the large airways and obtain BAL fluid for GM testing and fungal and bacterial cultures.
T87 13573-13716 Sentence denotes Testing is most appropriate in patients who are on mechanical ventilation, but the diagnostic strategy is less clear in patients not intubated.
T88 13717-13881 Sentence denotes As up to 50% of patients may present with tracheobronchitis, the presence of plaques and ulceration might be considered for inclusion in the definition of IPA [35].
T89 13882-14035 Sentence denotes Policies for taking biopsies of lesions seen on bronchoscopy may vary, mainly because of concerns about the risk of bleeding with biopsy in ICU patients.
T90 14036-14109 Sentence denotes The use of a flexible brush may also be sufficient to make the diagnosis.
T91 14110-14232 Sentence denotes Although a positive serum GM is highly indicative of IA, BAL GM can be positive in patients with Aspergillus colonization.
T92 14233-14321 Sentence denotes It therefore does not absolutely discriminate between colonization and invasive disease.
T93 14322-14404 Sentence denotes However, it clearly makes it more likely that an invasive disease is present [36].
T94 14406-14428 Sentence denotes Use of corticosteroids
T95 14429-14557 Sentence denotes Corticosteroids should not be given to influenza patients as their use may be associated with increased risk of IAPA [7, 37–39].
T96 14558-14707 Sentence denotes A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40].
T97 14708-14767 Sentence denotes However, the evidence was almost exclusively observational.
T98 14768-14955 Sentence denotes Furthermore, patients are often given steroids in the first few days preceding or after ICU admission for a variety of reasons including COPD exacerbation or complications such as sepsis.
T99 14956-15142 Sentence denotes With surveys suggesting that approximately half of the physicians are not aware of IAPA [24], many physicians may additionally not be aware of the potential drawbacks of corticosteroids.
T100 15143-15327 Sentence denotes Whenever the use of corticosteroids is unavoidable, more efforts (bronchoscopy with GM detection in BAL fluid or serum β-D-glucan test) should be made to exclude or diagnose IAPA [41].
T101 15329-15374 Sentence denotes Rationale for antifungal prophylaxis for IAPA
T102 15375-15571 Sentence denotes In settings with high IAPA rates in ICU patients with influenza pneumonia, an antifungal prophylaxis strategy might be appropriate, particularly as IAPA typically occurs early after ICU admission.
T103 15572-15679 Sentence denotes However, there is currently no mold-active antifungal agent licensed for prophylaxis of IA in ICU patients.
T104 15680-15834 Sentence denotes Posaconazole (POS) prophylaxis reduces the prevalence of IA in neutropenic AML patients and those with graft-versus-host disease following alloHCT [2, 3].
T105 15835-15958 Sentence denotes Based on this proof-of-principle, it has been hypothesized that POS prophylaxis can reduce IAPA prevalence in ICU patients.
T106 15959-16134 Sentence denotes Intravenous (IV) administration of POS prophylaxis in the ICU is favored in patients on mechanical ventilation or with a high likelihood of malabsorption of oral formulations.
T107 16135-16237 Sentence denotes POS IV formulation should be administered through a central catheter due to its acidity (pH 3.2) [42].
T108 16239-16291 Sentence denotes Treatment options and challenges for IAPA in the ICU
T109 16292-16377 Sentence denotes First-line treatment options for IPA include voriconazole and isavuconazole [35, 43].
T110 16378-16620 Sentence denotes Other options include echinocandins in combination with anti-mold azoles, and liposomal amphotericin B (L-AmB) in regions with high rates of azole-resistant A. fumigatus, although clinical data with L-AmB in ICU patients are limited [43, 44].
T111 16621-16751 Sentence denotes Achieving adequate drug exposure is challenging in ICU patients with multiple factors contributing to pharmacokinetic variability.
T112 16752-16938 Sentence denotes Unlike L-AmB and the echinocandins, drug interactions are clinically relevant for the azoles and pharmacogenetic factors are important in inter-individual drug exposure variability [45].
T113 16939-17075 Sentence denotes The impact of therapeutic drug monitoring (TDM) for voriconazole shows a clear relation between exposure and both efficacy and toxicity.
T114 17076-17321 Sentence denotes Target plasma trough voriconazole concentrations of ≥ 1.5–2 mg/L are associated with near-maximal clinical response in treatment of IA with a wild-type phenotype [46–51], with higher exposures (> 5.5 mg/L) increasing the risk of (neuro)toxicity.
T115 17322-17449 Sentence denotes Higher trough concentrations (> 2 mg/L) are recommended for treatment of pathogens with elevated MICs (e.g., > 0.25 mg/L) [52].
T116 17450-17641 Sentence denotes For isavuconazole, there is no robust target plasma concentration, and the population average exposure of participants that demonstrated a favorable response (2–4 mg/L) is commonly used [43].
T117 17643-17720 Sentence denotes Discussion on antifungal treatment options and challenges for IAPA in the ICU
T118 17721-18057 Sentence denotes A specific drug–drug interaction is relevant for patients with IAPA given the fact that co-infections with S. aureus are frequently observed; undetectable voriconazole levels have been observed in 11 of 20 patients, who were concomitantly treated with flucloxacillin [53], but the mechanisms of interaction are not yet fully understood.
T119 18058-18116 Sentence denotes Similar interactions have not been seen with other azoles.
T120 18117-18218 Sentence denotes Many other drug interactions with azoles and drugs commonly deployed in the ICU can be expected [45].
T121 18219-18425 Sentence denotes Aerosolized antifungal treatment may be a useful adjunctive therapy to systemic antifungal therapy for patients with confirmed Aspergillus tracheobronchitis, to achieve good endobronchial exposure [35, 54].
T122 18426-18608 Sentence denotes However, dense lipophilic plaques in the trachea may be difficult to penetrate and more research is needed into when and how to use aerosolized antifungals as well as their efficacy.
T123 18609-18842 Sentence denotes The ECCMID/ECMM/ERS Aspergillus guideline reviewed the teratogenic and mutagenic potential of antifungals in early pregnancy and recommends that azoles should be avoided, with polyenes being considered the preferred therapy [43, 55].
T124 18843-18952 Sentence denotes Thus, for pregnant patients at risk of IAPA a diagnostic approach was preferred above antifungal prophylaxis.
T125 18953-19033 Sentence denotes There is little evidence on the impact of ECMO on antifungal drug exposure [56].
T126 19034-19091 Sentence denotes For the echinocandins, an impact of ECMO is not expected.
T127 19092-19217 Sentence denotes Experts felt that, given these uncertainties, TDM of any antifungal used would be advised to ensure sufficient drug exposure.
T128 19219-19253 Sentence denotes Consensus case definition for IAPA
T129 19254-19585 Sentence denotes The expert panel discussed which case definition of IAPA would be appropriate to use in clinical studies, initially considering various aspects regarding four main areas of focus: entry criteria of the consensus definition, host, clinical features and mycological evidence similar to the currently used EORTC/MSGERC classification.
T130 19587-19602 Sentence denotes Entry criterion
T131 19603-19778 Sentence denotes In addition to having a positive diagnostic test for influenza, patients would require to have a clinical syndrome compatible with influenza disease as part of the definition.
T132 19779-19867 Sentence denotes This criterion should be termed the ‘entry criterion’ and not ‘host factor’ for clarity.
T133 19868-20173 Sentence denotes To avoid the risk of missing patients who initially tested negative with a rapid influenza antigen test but subsequently tested positive (by PCR) for influenza when admitted to hospital, a recommendation on a timescale, such as between 1 week before ICU admission and 72–96 h post-admission, was included.
T134 20174-20357 Sentence denotes The consensus on the entry criterion was: a patient requiring ICU admission for respiratory distress with a positive influenza PCR or antigen test temporally related to ICU admission.
T135 20359-20371 Sentence denotes Host factors
T136 20372-20668 Sentence denotes Host factors are considered in the EORTC/MSGERC definition and AspICU algorithm [10, 11], but the system of taking host factors into account was a necessity because the risk of a false-positive Aspergillus test increases substantially when the test is done in patients at low risk of the disease.
T137 20669-20811 Sentence denotes Clinicians had to take into account the type of host in order to increase the pretest probability of an invasive fungal disease being present.
T138 20812-20994 Sentence denotes However, for IAPA the key question is whether the disease is present or not, and not whether the patient group has a higher risk than other patient groups for developing the disease.
T139 20995-21120 Sentence denotes More importantly, the incidence of IAPA in patients admitted to the ICU with influenza may be higher in some centers [9, 21].
T140 21121-21219 Sentence denotes No further host factors are needed to increase the pretest probability in this patient population.
T141 21220-21366 Sentence denotes Although most IAPA cases have at least one underlying condition or steroid use, host factors were not be included in the case definition for IAPA.
T142 21368-21420 Sentence denotes Criteria to define proven and probable cases of IAPA
T143 21421-21598 Sentence denotes The distinction between proven and probable IAPA is important for clinical trials, while in clinical practice, people should not distinguish between proven and probable disease.
T144 21599-21845 Sentence denotes The criteria for proven disease include a patient fulfilling the entry criterion plus histological evidence of invasive fungal elements and mycological evidence for the presence of Aspergillus (obtained by Aspergillus PCR or culture from tissue).
T145 21846-22048 Sentence denotes Tracheobronchitis (tracheal and/or bronchial ulcerations or nodules, pseudomembranes or plaques visualized at bronchoscopy), as also described in the EORTC/MSGERC definitions [10], is a separate entity.
T146 22049-22326 Sentence denotes Although a tissue biopsy would normally be required to prove a case of IAPA, in tracheobronchitis cases hyphal elements suggestive of Aspergillus seen on sloughed-off pseudomembrane, and Aspergillus identified on culture or PCR, can also be considered proven disease (Table 1).
T147 22327-22384 Sentence denotes Table 1 Proposed case definition for IAPA in ICU patients
T148 22385-22485 Sentence denotes Entry criteria: influenza-like illness + positive influenza PCR or antigen + temporally relationship
T149 22486-22581 Sentence denotes Aspergillus tracheobronchitis IAPA in patients without documented Aspergillus tracheobronchitis
T150 22582-22868 Sentence denotes Proven Biopsy or brush specimen of airway plaque, pseudomembrane or ulcer showing hyphal elements and Aspergillus growth on culture or positive Aspergillus PCR in tissue Lung biopsy showing invasive fungal elements and Aspergillus growth on culture or positive Aspergillus PCR in tissue
T151 22869-22916 Sentence denotes Probable Airway plaque, pseudomembrane or ulcer
T152 22917-22951 Sentence denotes and at least one of the following:
T153 22952-22972 Sentence denotes Serum GM index > 0.5
T154 22973-22975 Sentence denotes or
T155 22976-22994 Sentence denotes BAL GM index ≥ 1.0
T156 22995-22997 Sentence denotes or
T157 22998-23018 Sentence denotes Positive BAL culture
T158 23019-23021 Sentence denotes or
T159 23022-23056 Sentence denotes Positive tracheal aspirate culture
T160 23057-23059 Sentence denotes or
T161 23060-23083 Sentence denotes Positive sputum culture
T162 23084-23086 Sentence denotes or
T163 23087-23124 Sentence denotes Hyphae consistent with Aspergillus A:
T164 23125-23145 Sentence denotes Pulmonary infiltrate
T165 23146-23180 Sentence denotes and at least one of the following:
T166 23181-23201 Sentence denotes Serum GM index > 0.5
T167 23202-23204 Sentence denotes or
T168 23205-23223 Sentence denotes BAL GM index ≥ 1.0
T169 23224-23226 Sentence denotes or
T170 23227-23247 Sentence denotes Positive BAL culture
T171 23248-23250 Sentence denotes OR
T172 23251-23253 Sentence denotes B:
T173 23254-23309 Sentence denotes Cavitating infiltrate (not attributed to another cause)
T174 23310-23344 Sentence denotes and at least one of the following:
T175 23345-23368 Sentence denotes Positive sputum culture
T176 23369-23371 Sentence denotes or
T177 23372-23406 Sentence denotes Positive tracheal aspirate culture
T178 23407-23508 Sentence denotes A patient fulfilling the case definition of probable IAPA is required to fulfill the entry criterion.
T179 23509-23732 Sentence denotes A positive serum GM (GM index > 0.5) is important evidence for the diagnosis of IAPA, in patients with pulmonary infiltrates on chest X-ray or other imaging modality or bronchoscopic evidence of tracheobronchitis (Table 1).
T180 23733-23799 Sentence denotes In patients with tracheobronchitis, an infiltrate is not required.
T181 23800-23992 Sentence denotes In patients with endobronchial plaques or pulmonary infiltrates, a positive BAL GM or culture of a tracheal aspirate is considered mycological evidence that supports a probable IAPA diagnosis.
T182 23993-24148 Sentence denotes In patients with bacterial pneumonia where Aspergillus is cultured only from a sputum sample, there may be a risk of overdiagnosis and thus over-treatment.
T183 24149-24353 Sentence denotes For clinical practice, clinicians should take into account that a positive culture of an upper airway sample may indicate IAPA, but that confirmation with serum or BAL GM or BAL culture should be pursued.
T184 24354-24512 Sentence denotes However, one problem is that the background incidence varies in different regions, making it difficult to develop generalized guidelines that apply uniformly.
T185 24513-24619 Sentence denotes The significance of a positive sputum culture thus depends on the background incidence in a specific unit.
T186 24620-24839 Sentence denotes Although any Aspergillus-positive respiratory sample is in itself insufficient to classify patients as probable IAPA, a new pulmonary cavitating infiltrate is indicative of IAPA in patients who meet the entry criterion.
T187 24840-25033 Sentence denotes Therefore, any Aspergillus-positive respiratory sample is sufficient evidence to classify patients as probable IAPA provided that a pulmonary cavitating infiltrate is present (Table 1; Fig. 1).
T188 25034-25280 Sentence denotes Fig. 1 Flowchart of probable IAPA classification. (*)If hyphae consistent with Aspergillus are documented in a biopsy of an airway lesion AND Aspergillus is grown from sputum or a tracheal aspirate, the case fulfills the definition of proven IAPA
T189 25281-25494 Sentence denotes A BAL GM index cutoff of ≥ 1.0 is recommended as this cutoff value ensures high specificity, without decreasing sensitivity significantly, which is also in line with other definitions and recommendations [10, 57].
T190 25495-25656 Sentence denotes Aspergillus PCR is not recommended as a primary diagnostic tool because of concerns about its reliability and positive predictive value for the diagnosis of IPA.
T191 25657-25784 Sentence denotes However, Aspergillus PCR is recommended in the proven category because it enables Aspergillus identification in tissue samples.
T192 25785-25895 Sentence denotes In some patients, discordant results are obtained, for instance a positive sputum culture but negative BAL GM.
T193 25896-26142 Sentence denotes For most situations, IAPA classification relies on a positive GM test, as a positive sputum culture with a negative GM result would be interpreted as a lower probability of IAPA (unless a pulmonary cavity or tracheobronchitis is present)(Fig. 1).
T194 26144-26154 Sentence denotes Conclusion
T195 26155-26357 Sentence denotes IAPA has emerged as a severe complication of influenza, especially in ICU patients, and this secondary infection may occur in any patient, including those considered to be at low risk of developing IPA.
T196 26358-26456 Sentence denotes The global epidemiology of IAPA may be variable, which might be partly due to underdiagnosis [24].
T197 26457-26629 Sentence denotes The clinical presentation of IAPA includes invasive Aspergillus tracheobronchitis, which requires bronchoscopic visualization of plaques in the airways to make a diagnosis.
T198 26630-26767 Sentence denotes Aspergillus culture and BAL GM are positive in > 80% of IAPA cases, and ordering such tests is recommended in influenza cases in the ICU.
T199 26768-26898 Sentence denotes The proposed case definition relies on an entry criterion based on an influenza-like illness and the detection of influenza virus.
T200 26899-27102 Sentence denotes The case definition distinguishes between invasive tracheobronchitis and other pulmonary forms of IAPA, with demonstration of invasive fungal hyphae with positive mycology qualifying as proven infection.
T201 27103-27219 Sentence denotes Detection of GM or positive Aspergillus culture in BAL is the main mycological criteria in probable case definition.
T202 27220-27515 Sentence denotes The expert group acknowledges that to date still limited data exist to support a definitive approach regarding definitions, diagnosis and treatment of IAPA, but the proposed case definition will facilitate clinical research, will enable valid study comparisons and is essential for surveillance.
T203 27516-27672 Sentence denotes Awareness of IAPA and early antifungal therapy based on high clinical suspicion and Aspergillus diagnostics remains critical to improve the outcome of IAPA.
T204 27674-27757 Sentence denotes Can the IAPA definitions be applied to COVID-19-associated pulmonary aspergillosis?
T205 27758-27975 Sentence denotes Recent reports of IPA cases in coronavirus disease 2019 (COVID-19) patients in the ICU raise the question of whether these IAPA definitions can be applied to COVID-19-associated pulmonary aspergillosis (CAPA) [58–60].
T206 27976-28182 Sentence denotes Although the number of CAPA cases that have been reported is still limited, two recent studies reported putative CAPA cases in 9 of 27 (33%) and 5 of 19 (26%) COVID-19 patients admitted to the ICU [59, 60].
T207 28183-28397 Sentence denotes Although the high number of cases suggests a high risk of developing IPA in COVID-19 patients, there are a number of differences regarding the pathogenesis of SARS-CoV-2 infection compared with influenza (Table 2).
T208 28398-28710 Sentence denotes In influenza patients, there are several factors that are thought to contribute to the risk of IAPA, including the local tissue damage caused by influenza, an immune modulatory effect by suppression of the NADPH oxidase complex and possible effect of treatment with neuraminidase inhibitors, such as oseltamivir.
T209 28711-28856 Sentence denotes In SARS-CoV-2 infection, another receptor is used by the virus to enter human cells, which are not commonly found in the large airways (Table 2).
T210 28857-28954 Sentence denotes Thus, the risk of invasive Aspergillus tracheobronchitis may be lower in CAPA compared with IAPA.
T211 28955-29097 Sentence denotes In addition, there is no known direct immune modulatory effect of SARS-CoV-2, which suggests no virus infection-related increased risk of IPA.
T212 29098-29245 Sentence denotes While IAPA is characterized by rapidly fatal infections with high fungal burden, such course of disease progression has not been reported for CAPA.
T213 29246-29419 Sentence denotes On the contrary, eight of nine CAPA cases reported from a French cohort did not receive antifungal therapy, with a mortality rate similar to COVID-19 cases without IPA [59].
T214 29420-29625 Sentence denotes As, in contrast to IAPA cases, virtually all CAPA cases reported to date are serum GM negative, the question remains if COVID-19 patients develop invasive disease or just become colonized with Aspergillus.
T215 29626-29841 Sentence denotes It is possible that COVID-19 is in itself not a risk factor for IPA, but that the risk is associated with other risk factors related to treatment such as administration of corticosteroids or underlying host factors.
T216 29842-30002 Sentence denotes Nevertheless, the high rate of Aspergillus recovered from COVID-19 patients suggests that there might be conditions that favor growth of the fungus in the lung.
T217 30003-30256 Sentence denotes We think that the proposed IAPA case definitions may be considered for classification of CAPA patients, while awaiting further histopathological studies that provide more insight into the interaction between Aspergillus and the SARS-CoV-2-infected lung.
T218 30257-30316 Sentence denotes Table 2 Comparison between characteristics of IAPA and CAPA
T219 30317-30333 Sentence denotes Factor IAPA CAPA
T220 30334-30432 Sentence denotes Host/Risk 57% EORTC/MSGERC host factor negative [9] 85% EORTC/MSGERC host factor negative [59, 60]
T221 30433-30552 Sentence denotes IAPA associated with corticosteroid use [7] IPA developed in SARS-2003-infected patients receiving corticosteroids [61]
T222 30553-30655 Sentence denotes Lymphopenia and chemokine-producing monocyte-derived FCN1 + macrophages causing hyperinflammation [62]
T223 30656-30824 Sentence denotes Virus Cell entry through sialic acids-2,6Gal: epithelial layer in lung including larger airways [63] Cell entry through ACE2: type 2 pneumocytes and ciliated cells [64]
T224 30825-31027 Sentence denotes Immune modulation by suppression of the NADPH oxidase complex [65] No evidence for immunomodulatory effect on known antifungal host defense mechanisms, although this has not been extensively studied yet
T225 31028-31179 Sentence denotes Fungal infection Invasive Aspergillus tracheobronchitis in up to 55% of patients [7–9] Invasive Aspergillus tracheobronchitis not yet reported [59, 60]
T226 31180-31312 Sentence denotes Median time between ICU admission and IAPA diagnosis 2–3 days [7–9] Median time between ICU admission and CAPA diagnosis 6 days [59]
T227 31313-31443 Sentence denotes Aspergillus diagnostics BAL GM positive in > 88% [7–9] BAL GM commonly positive, diagnostic performance currently unknown [59, 60]
T228 31444-31536 Sentence denotes Serum GM positive in 65% [7–9] Serum GM positive in 3 of 14 (21%) COVID-19 patients [59, 60]
T229 31537-31736 Sentence denotes Secondary infections In 80 of 342 (23.4%) ICU patients, most frequent pathogens S. pneumoniae, Pseudomonas aeruginosa and S. aureus [66] In four of 13 (31%) ICU patients, pathogens not specified [67]
T230 31737-32058 Sentence denotes ICU mortality 45% in IAPA compared with 20% in influenza without IAPA (p < 0.0001) [9] 33% in CAPA cases compared with 17% in COVID-19 without CAPA (p = 0.4) [59] (although mortality rates due to COVID-19 without CAPA vary enormous between countries and we have no clear data yet on the true mortality in ICU of COVID-19)
T231 32060-32071 Sentence denotes Disclaimer:
T232 32072-32245 Sentence denotes The findings and conclusions in this report those of the authors do not necessarily represent the official positions of the Centers for Disease Control and Prevention (CDC).
T233 32246-32262 Sentence denotes Publisher's Note
T234 32263-32381 Sentence denotes Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
T235 32383-32403 Sentence denotes Author contributions
T236 32404-32503 Sentence denotes An expert meeting was organized by PEV, RJMB, JW and FLvdV and held in Amsterdam on April 16, 2019.
T237 32504-32618 Sentence denotes Present at the expert meeting were PEV, BJAR, RJMB, SB, CJC, OAC, DRG, NAFJ, BJK, KL, JM, MHN, TFP, TRR and FLvdV.
T238 32619-32735 Sentence denotes A first draft manuscript was prepared by PEV, BJAR, RJMB, JW and FLvdV and circulated for comments from all experts.
T239 32736-32789 Sentence denotes All experts reviewed and commented on the manuscript.
T240 32790-32856 Sentence denotes Using these comments, a final version was circulated for approval.
T241 32858-32865 Sentence denotes Funding
T242 32866-32902 Sentence denotes The meeting was supported by Pfizer.
T243 32903-33007 Sentence denotes Pfizer had no role in the topics discussed nor were they involved in drafting of the consensus document.
T244 33009-33042 Sentence denotes Compliance with ethical standards
T245 33044-33065 Sentence denotes Conflicts of interest
T246 33066-33208 Sentence denotes PE Verweij reported grants from Gilead Sciences, MSD, Pfizer and F2G, and non-financial support from OLM and IMMY, outside the submitted work.
T247 33209-33580 Sentence denotes BJA Rijnders was the investigator for studies supported by Gilead Sciences, Janssen-Cilag, MSD, Pfizer, ViiV; has received research grants from Gilead and MSD; was an invited speaker for Gilead, MSD, Pfizer, Jansen-Cilag, BMS; and an advisory board member for BMS, Abbvie, MSD, Gilead, Jansen-Cilag; he received travel support from BMS, Abbvie, MSD, Gilead, Jansen-Cilag.
T248 33581-33858 Sentence denotes RJM Brüggemann served as a consultant to Astellas Pharma, Inc., F2G, Amplyx, Gilead Sciences, Merck Sharp & Dohme Corp., and Pfizer, Inc., and has received unrestricted and research grants from Astellas Pharma, Inc., Gilead Sciences, Merck Sharp & Dohme Corp., and Pfizer, Inc.
T249 33859-33943 Sentence denotes All contracts were through Radboudumc, and all payments were invoiced by Radboudumc.
T250 33944-34030 Sentence denotes E Azoulay has received fees for lectures from Pfizer, Gilead, MSD, Alexion and Baxter.
T251 34031-34117 Sentence denotes His institution received research support from Fisher&Payckle, Jazz pharma and Gilead.
T252 34118-34421 Sentence denotes M Bassetti has received funding for scientific advisory boards, travel and speaker honoraria from Angelini, Astellas, AstraZeneca, Basilea, Bayer, BioMèrieux, Cidara, Correvio, Cubist, Menarini, Molteni, MSD, Nabriva, Paratek, Pfizer, Roche, Shionogi, Tetraphase, Thermo Fisher and The Medicine Company.
T253 34422-34568 Sentence denotes S Blot received research funding from Pfizer and MSD, travel support from Pfizer, MSD and Gilead, and is an invited speaker for Pfizer and Gilead.
T254 34569-34772 Sentence denotes T Calandra reported advisory board membership from Astellas, Basilea, Cidara, MSD, Sobi, ThermoFisher and GE Healthcare and data monitoring board membership from Novartis, all outside the submitted work.
T255 34773-34806 Sentence denotes Fees are paid to its institution.
T256 34807-35152 Sentence denotes CJ Clancy has been awarded investigator-initiated research grants from Astellas, Merck, Melinta and Cidara for projects unrelated to this project, served on advisory boards or consulted for Astellas, Merck, the Medicines Company, Cidara, Scynexis, Shionogi, Qpex and Needham & Company, and spoken at symposia sponsored by Merck and T2Biosystems.
T257 35153-35714 Sentence denotes OA Cornely is supported by the German Federal Ministry of Research and Education and the European Commission, and has received research grants from, is an advisor to, or received lecture honoraria from Actelion, Allecra Therapeutics, Amplyx, Astellas, Basilea, Biosys UK Limited, Cidara, Da Volterra, Entasis, F2G, Gilead, Grupo Biotoscana, Janssen Pharmaceuticals, Matinas, Medicines Company, MedPace, Melinta Therapeutics, Menarini Ricerche, Merck/MSD, Octapharma, Paratek Pharmaceuticals, Pfizer, PSI, Rempex, Scynexis, Seres Therapeutics, Tetraphase, Vical.
T258 35715-35759 Sentence denotes T Chiller reported no conflicts of interest.
T259 35760-35804 Sentence denotes P Depuydt reported no conflicts of interest.
T260 35805-35906 Sentence denotes DR Giacobbe reported honoraria from Stepstone Pharma GmbH and an unconditional grant from MSD Italia.
T261 35907-35953 Sentence denotes NAF Janssen reported no conflicts of interest.
T262 35954-36028 Sentence denotes BJ Kullberg has been a scientific advisor for Amplyx, Cidara and Scynexis.
T263 36029-36196 Sentence denotes K Lagrou received consultancy fees from MSD, SMB Laboratoires Brussels and Gilead, travel support from Pfizer and MSD and speaker fees from Gilead, MSD, FUJIFILM WAKO.
T264 36197-36360 Sentence denotes C Lass-Florl received research funding from Pfizer, Gilead and Egger, travel support from Pfizer, MSD, and Gilead, and is an invited speaker for Pfizer and Gilead.
T265 36361-36467 Sentence denotes RE Lewis has received research support from Merck and has served as an invited speaker for Gilead, Cidara.
T266 36468-36644 Sentence denotes P Wei-Lun Liu has received research grants from MSD, Pfizer, and has served as an invited speaker for Gilead, MSD, Pfizer, Astellas Pharma, and is an advisor to Pfizer, Gilead.
T267 36645-36782 Sentence denotes O Lortholary has served as an invited speaker for Gilead, MSD, Pfizer, Astellas Pharma, and is a consultant for Gilead, Novartis and F2G.
T268 36783-37019 Sentence denotes J Maertens reported personal fees and non-financial support from Basilea Pharmaceuticals, Bio-Rad Laboratories, Cidara, F2G Ltd., Gilead Sciences, Merck, Astellas, Scynexis, and Pfizer Inc. and grants from Gilead Sciences, IMMY and OLM.
T269 37020-37071 Sentence denotes I Martin-Loeches reported no conflicts of interest.
T270 37072-37312 Sentence denotes MH Nguyen has been awarded investigator-initiated research grants from Astellas, Merck, Melinta and Cidara for projects unrelated to this study and served on advisory boards for Astellas, Merck, the Medicines Company, Scynexis and Shionogi.
T271 37313-37509 Sentence denotes TF Patterson reported grants from Cidara to UT Health San Antonio; personal fees from Basilea, Gilead, Mayne, Merck, Pfizer, Scynexis, Sfunga, Toyama and United Medical outside the submitted work.
T272 37510-37683 Sentence denotes TR Rogers has received grants from Gilead Sciences, lecture honoraria from Gilead Sciences and Pfizer Healthcare Ireland, and advisory board membership with Menarini Pharma.
T273 37684-37797 Sentence denotes JA Schouten has received unrestricted educational and research grants from MSD and has been an advisor to Pfizer.
T274 37798-37882 Sentence denotes All contracts were through Radboudumc, and all payments were invoiced by Radboudumc.
T275 37883-38002 Sentence denotes I Spriet has received unrestricted research grants, speaker fees and travel grants from MSD, Pfizer, Gilead and Cidara.
T276 38003-38051 Sentence denotes She has served in the advisory board for Cidara.
T277 38052-38161 Sentence denotes L Vanderbeke is supported by the Flanders Research Foundation (FWO Vlaanderen) through a doctoral fellowship.
T278 38162-38289 Sentence denotes J Wauters reported grants from Gilead Sciences, MSD and Pfizer, and non-financial support from MSD, outside the submitted work.
T279 38290-38353 Sentence denotes FL van de Veerdonk has served as an invited speaker for Gilead.

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T1 31-40 UBERON:0002048 denotes pulmonary
T2 152-161 UBERON:0002048 denotes pulmonary
T3 254-258 UBERON:0007221 denotes care
T4 324-333 UBERON:0002048 denotes pulmonary
T5 398-404 NCBITaxon:4751 denotes fungal
T6 723-732 SO:0000993 denotes consensus
T7 919-930 UBERON:0001004 denotes respiratory
T8 1120-1131 NCBITaxon:5052 denotes Aspergillus
T9 1173-1186 CHEBI:27680;CHEBI:27680 denotes galactomannan
T10 1199-1210 NCBITaxon:5052 denotes Aspergillus
T11 1222-1237 UBERON:0002186 denotes bronchoalveolar
T12 1254-1259 UBERON:0001977 denotes serum
T13 1265-1274 UBERON:0002048 denotes pulmonary
T14 1318-1329 UBERON:0001004 denotes respiratory
T15 1370-1387 UBERON:0007196 denotes tracheobronchitis
T16 1402-1411 UBERON:0002048 denotes pulmonary
T17 1507-1515 SP_7 denotes COVID-19
T18 1527-1536 UBERON:0002048 denotes pulmonary
T19 1645-1656 NCBITaxon:5052 denotes Aspergillus
T20 1665-1675 SP_7 denotes SARS-CoV-2
T21 1685-1689 UBERON:0002048 denotes lung
T22 1705-1714 SO:0000993 denotes consensus
T23 1930-1937 CHEBI:33695;CHEBI:33695;SO:0000673 denotes message
T24 1947-1956 UBERON:0002048 denotes pulmonary
T25 2097-2106 SO:0000993 denotes consensus
T26 2148-2157 UBERON:0002048 denotes pulmonary
T27 2259-2267 SP_7 denotes COVID-19
T28 2279-2288 UBERON:0002048 denotes pulmonary
T29 2327-2336 UBERON:0002048 denotes pulmonary
T30 2414-2425 NCBITaxon:1 denotes individuals
T31 2464-2474 CL:0000775 denotes neutrophil
T32 2488-2494 CL:0000084 denotes T cell
T33 2593-2610 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T34 3028-3037 CHEBI:76612;CHEBI:76612 denotes ibrutinib
T35 3252-3271 UBERON:0007221 denotes intensive care unit
T36 3355-3364 UBERON:0002048 denotes pulmonary
T37 3663-3674 NCBITaxon:1 denotes individuals
T38 3916-3925 SO:0000993 denotes consensus
T39 4690-4702 CHEBI:52217;CHEBI:52217 denotes pharmacology
T40 4875-4881 NCBITaxon:4751 denotes fungal
T41 4894-4900 NCBITaxon:4751 denotes fungal
T42 5047-5056 SO:0000993 denotes consensus
T43 5410-5419 SO:0000993 denotes consensus
T44 7008-7032 NCBITaxon:1313 denotes Streptococcus pneumoniae
T45 7036-7057 NCBITaxon:1280 denotes Staphylococcus aureus
T46 7651-7660 NCBITaxon:7719 denotes influenza
T47 7667-7676 NCBITaxon:7719 denotes influenza
T48 7679-7686 NCBITaxon:10239 denotes viruses
T49 8151-8166 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T50 8272-8283 NCBITaxon:5052 denotes Aspergillus
T51 8291-8304 CHEBI:27680;CHEBI:27680 denotes galactomannan
T52 8680-8691 CHEBI:7798;CHEBI:7798 denotes oseltamivir
T53 8695-8704 CHEBI:50663;CHEBI:50663 denotes zanamivir
T54 9009-9015 UBERON:0002405 denotes immune
T55 9057-9067 UBERON:0000483 denotes epithelium
T56 9095-9101 NCBITaxon:4751 denotes fungal
T57 9124-9128 UBERON:0002048 denotes lung
T58 9239-9248 NCBITaxon:2 denotes bacterial
T59 9334-9339 UBERON:0000033 denotes heads
T60 9366-9373 UBERON:0002185 denotes bronchi
T61 9414-9418 UBERON:0002048 denotes lung
T62 9419-9425 UBERON:0000479 denotes tissue
T63 9427-9438 GO:0030435 denotes Sporulation
T64 9466-9472 NCBITaxon:4751 denotes fungal
T65 9517-9521 UBERON:0002048 denotes lung
T66 9588-9592 UBERON:0002048 denotes lung
T67 9668-9683 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T68 9705-9715 CHEBI:35222;CHEBI:35222 denotes inhibitors
T69 9725-9736 CHEBI:7798;CHEBI:7798 denotes oseltamivir
T70 10201-10210 SO:0000993 denotes consensus
T71 10370-10375 UBERON:0001977 denotes serum
T72 10447-10458 NCBITaxon:5052 denotes Aspergillus
T73 10501-10522 NCBITaxon:746128 denotes Aspergillus fumigatus
T74 10549-10562 UBERON:0001852 denotes endobronchial
T75 10630-10647 UBERON:0007196 denotes tracheobronchitis
T76 10819-10824 UBERON:0001977 denotes serum
T77 10848-10854 UBERON:0007311 denotes sputum
T78 10855-10863 UBERON:0003126 denotes tracheal
T79 11113-11124 NCBITaxon:5052 denotes Aspergillus
T80 11125-11142 UBERON:0007196 denotes tracheobronchitis
T81 11144-11149 UBERON:0001443 denotes chest
T82 11166-11179 UBERON:0001845 denotes peribronchial
T83 11222-11228 UBERON:0001005 denotes airway
T84 11238-11249 NCBITaxon:5052 denotes Aspergillus
T85 11250-11267 UBERON:0007196 denotes tracheobronchitis
T86 11271-11281 UBERON:0000483 denotes epithelial
T87 11429-11438 UBERON:0002048 denotes pulmonary
T88 11524-11533 NCBITaxon:2 denotes bacterial
T89 11568-11581 CHEBI:35718;CHEBI:35718 denotes antimicrobial
T90 12514-12521 CHEBI:59132;CHEBI:59132 denotes antigen
T91 12624-12633 UBERON:0006314 denotes BAL fluid
T92 12668-12673 CHEBI:68452;CHEBI:68452 denotes azole
T93 12756-12761 CHEBI:68452;CHEBI:68452 denotes azole
T94 13012-13023 CHEBI:33282;CHEBI:33282 denotes antibiotics
T95 13043-13057 CHEBI:50858;CHEBI:50858 denotes corticosteroid
T96 13202-13211 UBERON:0002048 denotes pulmonary
T97 13374-13379 UBERON:0001977 denotes serum
T98 13392-13398 NCBITaxon:4751 denotes fungal
T99 13411-13417 UBERON:0007311 denotes sputum
T100 13425-13433 UBERON:0003126 denotes tracheal
T101 13444-13453 UBERON:0002048 denotes pulmonary
T102 13494-13501 UBERON:0001005 denotes airways
T103 13517-13522 UBERON:0006314 denotes fluid
T104 13542-13548 NCBITaxon:4751 denotes fungal
T105 13553-13562 NCBITaxon:2 denotes bacterial
T106 13759-13776 UBERON:0007196 denotes tracheobronchitis
T107 14130-14135 UBERON:0001977 denotes serum
T108 14207-14218 NCBITaxon:5052 denotes Aspergillus
T109 14413-14428 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T110 14429-14444 CHEBI:50858;CHEBI:50858 denotes Corticosteroids
T111 14623-14638 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T112 14806-14814 CHEBI:35341;CHEBI:35341 denotes steroids
T113 14905-14909 PR:000004197 denotes COPD
T114 15126-15141 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T115 15163-15178 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T116 15247-15252 UBERON:0006314 denotes fluid
T117 15256-15261 UBERON:0001977 denotes serum
T118 15680-15692 CHEBI:64355;CHEBI:64355 denotes Posaconazole
T119 16116-16120 UBERON:0000165 denotes oral
T120 16215-16222 CHEBI:37527;CHEBI:37527 denotes acidity
T121 16337-16349 CHEBI:10023;CHEBI:10023 denotes voriconazole
T122 16354-16367 CHEBI:85979;CHEBI:85979 denotes isavuconazole
T123 16400-16413 CHEBI:57248;CHEBI:57248 denotes echinocandins
T124 16466-16480 CHEBI:2682;CHEBI:2682 denotes amphotericin B
T125 16519-16524 CHEBI:68452;CHEBI:68452 denotes azole
T126 16536-16547 NCBITaxon:31032 denotes . fumigatus
T127 16640-16644 CHEBI:23888;CHEBI:23888 denotes drug
T128 16723-16738 CHEBI:52217;CHEBI:52217 denotes pharmacokinetic
T129 16773-16786 CHEBI:57248;CHEBI:57248 denotes echinocandins
T130 16788-16792 CHEBI:23888;CHEBI:23888 denotes drug
T131 16838-16844 CHEBI:68452;CHEBI:68452 denotes azoles
T132 16849-16864 CHEBI:52217;CHEBI:52217 denotes pharmacogenetic
T133 16896-16906 NCBITaxon:1 denotes individual
T134 16907-16911 CHEBI:23888;CHEBI:23888 denotes drug
T135 16965-16969 CHEBI:23888;CHEBI:23888 denotes drug
T136 16991-17003 CHEBI:10023;CHEBI:10023 denotes voriconazole
T137 17083-17089 UBERON:0001969 denotes plasma
T138 17097-17109 CHEBI:10023;CHEBI:10023 denotes voriconazole
T139 17454-17467 CHEBI:85979;CHEBI:85979 denotes isavuconazole
T140 17495-17501 UBERON:0001969 denotes plasma
T141 17732-17736 CHEBI:23888;CHEBI:23888 denotes drug
T142 17737-17741 CHEBI:23888;CHEBI:23888 denotes drug
T143 17828-17829 NCBITaxon:4932 denotes S
T144 17829-17830 NCBITaxon:562 denotes .
T145 17876-17888 CHEBI:10023;CHEBI:10023 denotes voriconazole
T146 17973-17987 CHEBI:5098;CHEBI:5098 denotes flucloxacillin
T147 18128-18132 CHEBI:23888;CHEBI:23888 denotes drug
T148 18151-18157 CHEBI:68452;CHEBI:68452 denotes azoles
T149 18162-18167 CHEBI:23888;CHEBI:23888 denotes drugs
T150 18346-18357 NCBITaxon:5052 denotes Aspergillus
T151 18358-18375 UBERON:0007196 denotes tracheobronchitis
T152 18393-18406 UBERON:0001852 denotes endobronchial
T153 18467-18474 UBERON:0003126 denotes trachea
T154 18570-18581 CHEBI:67079;CHEBI:67079 denotes antifungals
T155 18629-18640 NCBITaxon:5052 denotes Aspergillus
T156 18664-18675 CHEBI:50905;CHEBI:50905 denotes teratogenic
T157 18680-18689 CHEBI:25435;CHEBI:25435 denotes mutagenic
T158 18703-18714 CHEBI:35718;CHEBI:35718 denotes antifungals
T159 18724-18733 GO:0007565 denotes pregnancy
T160 18853-18861 GO:0007565 denotes pregnant
T161 19003-19013 CHEBI:35718;CHEBI:35718 denotes antifungal
T162 19014-19018 CHEBI:86327;CHEBI:86327 denotes drug
T163 19042-19055 CHEBI:57248;CHEBI:57248 denotes echinocandins
T164 19149-19159 CHEBI:35718;CHEBI:35718 denotes antifungal
T165 19203-19207 CHEBI:23888;CHEBI:23888 denotes drug
T166 19456-19465 SO:0000993 denotes consensus
T167 19959-19966 CHEBI:59132;CHEBI:59132 denotes antigen
T168 20254-20265 UBERON:0001004 denotes respiratory
T169 20308-20315 CHEBI:59132;CHEBI:59132 denotes antigen
T170 20782-20788 NCBITaxon:4751 denotes fungal
T171 21287-21294 CHEBI:35341;CHEBI:35341 denotes steroid
T172 21532-21538 NCBITaxon:9606 denotes people
T173 21837-21843 UBERON:0000479 denotes tissue
T174 21846-21863 UBERON:0007196 denotes Tracheobronchitis
T175 21865-21873 UBERON:0003126 denotes tracheal
T176 21915-21930 GO:0016020 denotes pseudomembranes
T177 22060-22066 UBERON:0000479 denotes tissue
T178 22129-22146 UBERON:0007196 denotes tracheobronchitis
T179 22452-22459 CHEBI:59132;CHEBI:59132 denotes antigen
T180 22552-22563 NCBITaxon:5052 denotes Aspergillus
T181 22617-22623 UBERON:0001005 denotes airway
T182 22684-22695 NCBITaxon:5052 denotes Aspergillus
T183 22726-22737 NCBITaxon:5052 denotes Aspergillus
T184 22745-22756 UBERON:0000479 denotes tissue Lung
T185 22843-22854 NCBITaxon:5052 denotes Aspergillus
T186 22862-22884 UBERON:0000479 denotes tissue Probable Airway
T187 22952-22957 UBERON:0001977 denotes Serum
T188 23031-23039 UBERON:0003126 denotes tracheal
T189 23069-23075 UBERON:0007311 denotes sputum
T190 23125-23134 UBERON:0002048 denotes Pulmonary
T191 23181-23186 UBERON:0001977 denotes Serum
T192 23354-23360 UBERON:0007311 denotes sputum
T193 23381-23389 UBERON:0003126 denotes tracheal
T203 23520-23525 UBERON:0001977 denotes serum
T204 23612-23621 UBERON:0002048 denotes pulmonary
T205 23637-23642 UBERON:0001443 denotes chest
T206 23704-23721 UBERON:0007196 denotes tracheobronchitis
T207 23750-23767 UBERON:0007196 denotes tracheobronchitis
T208 23817-23830 UBERON:0001852 denotes endobronchial
T209 23842-23851 UBERON:0002048 denotes pulmonary
T210 23899-23907 UBERON:0003126 denotes tracheal
T211 24010-24019 NCBITaxon:2 denotes bacterial
T212 24036-24047 NCBITaxon:5052 denotes Aspergillus
T213 24072-24078 UBERON:0007311 denotes sputum
T214 24238-24243 UBERON:0004908 denotes upper
T215 24244-24250 UBERON:0001005 denotes airway
T216 24304-24309 UBERON:0001977 denotes serum
T217 24544-24550 UBERON:0007311 denotes sputum
T218 24633-24644 NCBITaxon:5052 denotes Aspergillus
T219 24654-24665 UBERON:0001004 denotes respiratory
T220 24744-24753 UBERON:0002048 denotes pulmonary
T221 24855-24866 NCBITaxon:5052 denotes Aspergillus
T222 24876-24887 UBERON:0001004 denotes respiratory
T223 24972-24981 UBERON:0002048 denotes pulmonary
T224 25158-25164 UBERON:0001005 denotes airway
T225 25191-25196 GO:0040007 denotes grown
T226 25202-25208 UBERON:0007311 denotes sputum
T227 25214-25222 UBERON:0003126 denotes tracheal
T232 25666-25677 NCBITaxon:5052 denotes Aspergillus
T233 25739-25750 NCBITaxon:5052 denotes Aspergillus
T234 25769-25775 UBERON:0000479 denotes tissue
T235 25860-25866 UBERON:0007311 denotes sputum
T236 25981-25987 UBERON:0007311 denotes sputum
T237 26084-26093 UBERON:0002484 denotes pulmonary
T238 26094-26100 UBERON:0002224 denotes cavity
T239 26104-26121 UBERON:0007196 denotes tracheobronchitis
T240 26509-26520 NCBITaxon:5052 denotes Aspergillus
T241 26601-26608 UBERON:0001005 denotes airways
T242 26654-26657 SO:0000153 denotes BAL
T243 26882-26891 NCBITaxon:7719 denotes influenza
T244 26892-26897 NCBITaxon:10239 denotes virus
T245 26950-26967 UBERON:0007196 denotes tracheobronchitis
T246 26978-26987 UBERON:0002048 denotes pulmonary
T247 27034-27040 NCBITaxon:4751 denotes fungal
T248 27131-27142 NCBITaxon:5052 denotes Aspergillus
T249 27502-27514 GO:0065007 denotes surveillance
T250 27600-27611 NCBITaxon:5052 denotes Aspergillus
T251 27713-27721 SP_7 denotes COVID-19
T252 27733-27742 UBERON:0002048 denotes pulmonary
T253 27789-27800 NCBITaxon:11118 denotes coronavirus
T254 27815-27823 SP_7 denotes COVID-19
T255 27916-27924 SP_7 denotes COVID-19
T256 27936-27945 UBERON:0002048 denotes pulmonary
T257 28135-28143 SP_7 denotes COVID-19
T258 28259-28267 SP_7 denotes COVID-19
T259 28342-28352 SP_7 denotes SARS-CoV-2
T260 28519-28525 UBERON:0000479 denotes tissue
T261 28557-28563 UBERON:0002405 denotes immune
T262 28564-28574 GO:0065007 denotes modulatory
T263 28618-28625 GO:0043020 denotes complex
T264 28678-28688 CHEBI:35222;CHEBI:35222 denotes inhibitors
T265 28698-28709 CHEBI:7798;CHEBI:7798 denotes oseltamivir
T266 28714-28724 SP_7 denotes SARS-CoV-2
T267 28768-28773 NCBITaxon:10239 denotes virus
T268 28783-28788 SP_6;NCBITaxon:9606 denotes human
T269 28838-28845 UBERON:0001005 denotes airways
T270 28884-28895 NCBITaxon:5052 denotes Aspergillus
T271 28993-28999 UBERON:0002405;GO:0006955 denotes immune
T272 29000-29010 GO:0006955 denotes modulatory
T273 29021-29031 SP_7 denotes SARS-CoV-2
T274 29051-29056 NCBITaxon:10239 denotes virus
T275 29164-29170 NCBITaxon:4751 denotes fungal
T276 29387-29395 SP_7 denotes COVID-19
T277 29497-29502 UBERON:0001977 denotes serum
T278 29540-29548 SP_7 denotes COVID-19
T279 29646-29654 SP_7 denotes COVID-19
T280 29798-29813 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T281 29828-29832 GO:0018995 denotes host
T282 29873-29884 NCBITaxon:5052 denotes Aspergillus
T283 29900-29908 SP_7 denotes COVID-19
T284 29983-29989 NCBITaxon:4751 denotes fungus
T285 29997-30001 UBERON:0002048 denotes lung
T286 30231-30241 SP_7 denotes SARS-CoV-2
T287 30251-30255 UBERON:0002048 denotes lung
T288 30403-30407 GO:0018995 denotes host
T289 30454-30468 CHEBI:50858;CHEBI:50858 denotes corticosteroid
T290 30494-30498 SP_10 denotes SARS
T291 30532-30547 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T292 30589-30597 CL:0000576 denotes monocyte
T293 30606-30610 PR:000007437 denotes FCN1
T294 30613-30624 CL:0000235 denotes macrophages
T295 30681-30687 CHEBI:30563;CHEBI:30563 denotes sialic
T296 30688-30693 CHEBI:41865;CHEBI:41865 denotes acids
T297 30702-30712 UBERON:0000483 denotes epithelial
T298 30713-30718 UBERON:0000115 denotes layer
T299 30722-30726 UBERON:0002048 denotes lung
T300 30744-30751 UBERON:0001005 denotes airways
T301 30757-30767 GO:0035376 denotes Cell entry
T302 30776-30780 PR:000003622;G_3;PG_10 denotes ACE2
T303 30782-30800 CL:0002063 denotes type 2 pneumocytes
T304 30805-30819 CL:0000064 denotes ciliated cells
T305 30832-30842 GO:0065007 denotes modulation
T306 30865-30886 GO:0043020 denotes NADPH oxidase complex
T307 30957-30964 GO:0006952 denotes defense
T308 31066-31083 UBERON:0007196 denotes tracheobronchitis
T309 31444-31449 UBERON:0001977 denotes Serum
T310 31475-31480 UBERON:0001977 denotes Serum
T311 31510-31518 SP_7 denotes COVID-19
T312 31617-31619 NCBITaxon:4896 denotes S.
T313 31620-31630 NCBITaxon:31031 denotes pneumoniae
T314 31632-31643 NCBITaxon:286 denotes Pseudomonas
T315 31644-31654 NCBITaxon:8296 denotes aeruginosa
T316 31659-31660 NCBITaxon:4932 denotes S
T317 31660-31661 NCBITaxon:4896 denotes .
T318 31863-31871 SP_7 denotes COVID-19
T319 31933-31941 SP_7 denotes COVID-19
T320 32049-32057 SP_7 denotes COVID-19
T12120 31-40 UBERON:0002048 denotes pulmonary
T74802 152-161 UBERON:0002048 denotes pulmonary
T39139 254-258 UBERON:0007221 denotes care
T12430 324-333 UBERON:0002048 denotes pulmonary
T5245 398-404 NCBITaxon:4751 denotes fungal
T36609 723-732 SO:0000993 denotes consensus
T75692 919-930 UBERON:0001004 denotes respiratory
T84443 1120-1131 NCBITaxon:5052 denotes Aspergillus
T34269 1173-1186 CHEBI:27680;CHEBI:27680 denotes galactomannan
T60679 1199-1210 NCBITaxon:5052 denotes Aspergillus
T26342 1222-1237 UBERON:0002186 denotes bronchoalveolar
T99495 1254-1259 UBERON:0001977 denotes serum
T26592 1265-1274 UBERON:0002048 denotes pulmonary
T63277 1318-1329 UBERON:0001004 denotes respiratory
T58436 1370-1387 UBERON:0007196 denotes tracheobronchitis
T13528 1402-1411 UBERON:0002048 denotes pulmonary
T41590 1507-1515 SP_7 denotes COVID-19
T91554 1527-1536 UBERON:0002048 denotes pulmonary
T48258 1645-1656 NCBITaxon:5052 denotes Aspergillus
T27026 1665-1675 SP_7 denotes SARS-CoV-2
T42156 1685-1689 UBERON:0002048 denotes lung
T10504 1705-1714 SO:0000993 denotes consensus
T74523 1930-1937 CHEBI:33695;CHEBI:33695;SO:0000673 denotes message
T48066 1947-1956 UBERON:0002048 denotes pulmonary
T46771 2097-2106 SO:0000993 denotes consensus
T74529 2148-2157 UBERON:0002048 denotes pulmonary
T44124 2259-2267 SP_7 denotes COVID-19
T63961 2279-2288 UBERON:0002048 denotes pulmonary
T81322 2327-2336 UBERON:0002048 denotes pulmonary
T51311 2414-2425 NCBITaxon:1 denotes individuals
T81106 2464-2474 CL:0000775 denotes neutrophil
T17383 2488-2494 CL:0000084 denotes T cell
T96288 2593-2610 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T80755 3028-3037 CHEBI:76612;CHEBI:76612 denotes ibrutinib
T56421 3252-3271 UBERON:0007221 denotes intensive care unit
T62889 3355-3364 UBERON:0002048 denotes pulmonary
T75194 3663-3674 NCBITaxon:1 denotes individuals
T71433 3916-3925 SO:0000993 denotes consensus
T68350 4690-4702 CHEBI:52217;CHEBI:52217 denotes pharmacology
T21985 4875-4881 NCBITaxon:4751 denotes fungal
T87756 4894-4900 NCBITaxon:4751 denotes fungal
T42141 5047-5056 SO:0000993 denotes consensus
T46351 5410-5419 SO:0000993 denotes consensus
T23383 7008-7032 NCBITaxon:1313 denotes Streptococcus pneumoniae
T37236 7036-7057 NCBITaxon:1280 denotes Staphylococcus aureus
T36235 7651-7660 NCBITaxon:7719 denotes influenza
T90866 7667-7676 NCBITaxon:7719 denotes influenza
T82971 7679-7686 NCBITaxon:10239 denotes viruses
T40669 8151-8166 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T73349 8272-8283 NCBITaxon:5052 denotes Aspergillus
T73289 8291-8304 CHEBI:27680;CHEBI:27680 denotes galactomannan
T34533 8680-8691 CHEBI:7798;CHEBI:7798 denotes oseltamivir
T94297 8695-8704 CHEBI:50663;CHEBI:50663 denotes zanamivir
T36119 9009-9015 UBERON:0002405 denotes immune
T76747 9057-9067 UBERON:0000483 denotes epithelium
T77643 9095-9101 NCBITaxon:4751 denotes fungal
T24189 9124-9128 UBERON:0002048 denotes lung
T78724 9239-9248 NCBITaxon:2 denotes bacterial
T53463 9334-9339 UBERON:0000033 denotes heads
T89433 9366-9373 UBERON:0002185 denotes bronchi
T96055 9414-9418 UBERON:0002048 denotes lung
T50524 9419-9425 UBERON:0000479 denotes tissue
T48743 9427-9438 GO:0030435 denotes Sporulation
T26080 9466-9472 NCBITaxon:4751 denotes fungal
T64776 9517-9521 UBERON:0002048 denotes lung
T81352 9588-9592 UBERON:0002048 denotes lung
T78005 9668-9683 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T22610 9705-9715 CHEBI:35222;CHEBI:35222 denotes inhibitors
T97282 9725-9736 CHEBI:7798;CHEBI:7798 denotes oseltamivir
T73706 10201-10210 SO:0000993 denotes consensus
T23018 10370-10375 UBERON:0001977 denotes serum
T97663 10447-10458 NCBITaxon:5052 denotes Aspergillus
T79006 10501-10522 NCBITaxon:746128 denotes Aspergillus fumigatus
T56081 10549-10562 UBERON:0001852 denotes endobronchial
T28200 10630-10647 UBERON:0007196 denotes tracheobronchitis
T83389 10819-10824 UBERON:0001977 denotes serum
T54848 10848-10854 UBERON:0007311 denotes sputum
T80836 10855-10863 UBERON:0003126 denotes tracheal
T48603 11113-11124 NCBITaxon:5052 denotes Aspergillus
T84469 11125-11142 UBERON:0007196 denotes tracheobronchitis
T9111 11144-11149 UBERON:0001443 denotes chest
T12913 11166-11179 UBERON:0001845 denotes peribronchial
T37746 11222-11228 UBERON:0001005 denotes airway
T32093 11238-11249 NCBITaxon:5052 denotes Aspergillus
T90534 11250-11267 UBERON:0007196 denotes tracheobronchitis
T78753 11271-11281 UBERON:0000483 denotes epithelial
T63798 11429-11438 UBERON:0002048 denotes pulmonary
T2169 11524-11533 NCBITaxon:2 denotes bacterial
T80813 11568-11581 CHEBI:35718;CHEBI:35718 denotes antimicrobial
T68219 12514-12521 CHEBI:59132;CHEBI:59132 denotes antigen
T22792 12624-12633 UBERON:0006314 denotes BAL fluid
T68159 12668-12673 CHEBI:68452;CHEBI:68452 denotes azole
T29336 12756-12761 CHEBI:68452;CHEBI:68452 denotes azole
T94543 13012-13023 CHEBI:33282;CHEBI:33282 denotes antibiotics
T54450 13043-13057 CHEBI:50858;CHEBI:50858 denotes corticosteroid
T56564 13202-13211 UBERON:0002048 denotes pulmonary
T93733 13374-13379 UBERON:0001977 denotes serum
T7027 13392-13398 NCBITaxon:4751 denotes fungal
T1997 13411-13417 UBERON:0007311 denotes sputum
T25508 13425-13433 UBERON:0003126 denotes tracheal
T27731 13444-13453 UBERON:0002048 denotes pulmonary
T66249 13494-13501 UBERON:0001005 denotes airways
T68615 13517-13522 UBERON:0006314 denotes fluid
T43239 13542-13548 NCBITaxon:4751 denotes fungal
T51425 13553-13562 NCBITaxon:2 denotes bacterial
T29952 13759-13776 UBERON:0007196 denotes tracheobronchitis
T93605 14130-14135 UBERON:0001977 denotes serum
T4489 14207-14218 NCBITaxon:5052 denotes Aspergillus
T70117 14413-14428 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T48384 14429-14444 CHEBI:50858;CHEBI:50858 denotes Corticosteroids
T63590 14623-14638 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T32212 14806-14814 CHEBI:35341;CHEBI:35341 denotes steroids
T66911 14905-14909 PR:000004197 denotes COPD
T3164 15126-15141 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T20945 15163-15178 CHEBI:50858;CHEBI:50858 denotes corticosteroids
T18373 15247-15252 UBERON:0006314 denotes fluid
T59301 15256-15261 UBERON:0001977 denotes serum
T66121 15680-15692 CHEBI:64355;CHEBI:64355 denotes Posaconazole
T65652 16116-16120 UBERON:0000165 denotes oral
T18742 16215-16222 CHEBI:37527;CHEBI:37527 denotes acidity
T5801 16337-16349 CHEBI:10023;CHEBI:10023 denotes voriconazole
T2719 16354-16367 CHEBI:85979;CHEBI:85979 denotes isavuconazole
T2586 16400-16413 CHEBI:57248;CHEBI:57248 denotes echinocandins
T84468 16466-16480 CHEBI:2682;CHEBI:2682 denotes amphotericin B
T79778 16519-16524 CHEBI:68452;CHEBI:68452 denotes azole
T89235 16536-16547 NCBITaxon:31032 denotes . fumigatus
T94377 16640-16644 CHEBI:23888;CHEBI:23888 denotes drug
T13252 16723-16738 CHEBI:52217;CHEBI:52217 denotes pharmacokinetic
T78758 16773-16786 CHEBI:57248;CHEBI:57248 denotes echinocandins
T29529 16788-16792 CHEBI:23888;CHEBI:23888 denotes drug
T38907 16838-16844 CHEBI:68452;CHEBI:68452 denotes azoles
T39277 16849-16864 CHEBI:52217;CHEBI:52217 denotes pharmacogenetic
T4074 16896-16906 NCBITaxon:1 denotes individual
T42152 16907-16911 CHEBI:23888;CHEBI:23888 denotes drug
T23351 16965-16969 CHEBI:23888;CHEBI:23888 denotes drug
T23219 16991-17003 CHEBI:10023;CHEBI:10023 denotes voriconazole
T6563 17083-17089 UBERON:0001969 denotes plasma
T68072 17097-17109 CHEBI:10023;CHEBI:10023 denotes voriconazole
T73675 17454-17467 CHEBI:85979;CHEBI:85979 denotes isavuconazole
T42840 17495-17501 UBERON:0001969 denotes plasma
T5704 17732-17736 CHEBI:23888;CHEBI:23888 denotes drug
T23687 17737-17741 CHEBI:23888;CHEBI:23888 denotes drug
T76380 17828-17829 NCBITaxon:4932 denotes S
T2256 17829-17830 NCBITaxon:562 denotes .
T62223 17876-17888 CHEBI:10023;CHEBI:10023 denotes voriconazole
T32565 17973-17987 CHEBI:5098;CHEBI:5098 denotes flucloxacillin
T43236 18128-18132 CHEBI:23888;CHEBI:23888 denotes drug
T38702 18151-18157 CHEBI:68452;CHEBI:68452 denotes azoles
T74202 18162-18167 CHEBI:23888;CHEBI:23888 denotes drugs
T48860 18346-18357 NCBITaxon:5052 denotes Aspergillus
T84649 18358-18375 UBERON:0007196 denotes tracheobronchitis
T69891 18393-18406 UBERON:0001852 denotes endobronchial
T67622 18467-18474 UBERON:0003126 denotes trachea
T4317 18570-18581 CHEBI:67079;CHEBI:67079 denotes antifungals
T80540 18629-18640 NCBITaxon:5052 denotes Aspergillus
T31714 18664-18675 CHEBI:50905;CHEBI:50905 denotes teratogenic
T16663 18680-18689 CHEBI:25435;CHEBI:25435 denotes mutagenic
T53462 18703-18714 CHEBI:35718;CHEBI:35718 denotes antifungals
T49738 18724-18733 GO:0007565 denotes pregnancy
T22501 18853-18861 GO:0007565 denotes pregnant
T23823 19003-19013 CHEBI:35718;CHEBI:35718 denotes antifungal
T93737 19014-19018 CHEBI:86327;CHEBI:86327 denotes drug
T6922 19042-19055 CHEBI:57248;CHEBI:57248 denotes echinocandins
T46107 19149-19159 CHEBI:35718;CHEBI:35718 denotes antifungal
T54949 19203-19207 CHEBI:23888;CHEBI:23888 denotes drug
T20532 19456-19465 SO:0000993 denotes consensus
T83127 19959-19966 CHEBI:59132;CHEBI:59132 denotes antigen
T25997 20254-20265 UBERON:0001004 denotes respiratory
T71989 20308-20315 CHEBI:59132;CHEBI:59132 denotes antigen
T86391 20782-20788 NCBITaxon:4751 denotes fungal
T77467 21287-21294 CHEBI:35341;CHEBI:35341 denotes steroid
T35102 21532-21538 NCBITaxon:9606 denotes people
T51082 21837-21843 UBERON:0000479 denotes tissue
T42508 21846-21863 UBERON:0007196 denotes Tracheobronchitis
T94069 21865-21873 UBERON:0003126 denotes tracheal
T96085 21915-21930 GO:0016020 denotes pseudomembranes
T99308 22060-22066 UBERON:0000479 denotes tissue
T64133 22129-22146 UBERON:0007196 denotes tracheobronchitis
T58082 22452-22459 CHEBI:59132;CHEBI:59132 denotes antigen
T32414 22552-22563 NCBITaxon:5052 denotes Aspergillus
T84214 22617-22623 UBERON:0001005 denotes airway
T31396 22684-22695 NCBITaxon:5052 denotes Aspergillus
T3517 22726-22737 NCBITaxon:5052 denotes Aspergillus
T17695 22745-22756 UBERON:0000479 denotes tissue Lung
T59924 22843-22854 NCBITaxon:5052 denotes Aspergillus
T84504 22862-22884 UBERON:0000479 denotes tissue Probable Airway
T49668 22952-22957 UBERON:0001977 denotes Serum
T42816 23031-23039 UBERON:0003126 denotes tracheal
T82825 23069-23075 UBERON:0007311 denotes sputum
T7327 23125-23134 UBERON:0002048 denotes Pulmonary
T86954 23181-23186 UBERON:0001977 denotes Serum
T76040 23354-23360 UBERON:0007311 denotes sputum
T7513 23381-23389 UBERON:0003126 denotes tracheal
T198 25113-25124 NCBITaxon:5052 denotes Aspergillus
T342 31617-31619 NCBITaxon:4896 denotes S.
T23407 31620-31630 NCBITaxon:31031 denotes pneumoniae
T35842 31632-31643 NCBITaxon:286 denotes Pseudomonas
T24939 31644-31654 NCBITaxon:8296 denotes aeruginosa
T27555 31659-31660 NCBITaxon:4932 denotes S
T55957 31660-31661 NCBITaxon:4896 denotes .
T31088 31863-31871 SP_7 denotes COVID-19
T66943 31933-31941 SP_7 denotes COVID-19
T66351 32049-32057 SP_7 denotes COVID-19

2_test

Id Subject Object Predicate Lexical cue
32572532-25354514-47963394 2620-2621 25354514 denotes 1
32572532-29437588-47963395 3039-3040 29437588 denotes 4
32572532-372590-47963396 3147-3148 372590 denotes 6
32572532-22895826-47963397 3303-3304 22895826 denotes 7
32572532-28387526-47963397 3303-3304 28387526 denotes 7
32572532-30076119-47963397 3303-3304 30076119 denotes 7
32572532-22517788-47963398 4050-4052 22517788 denotes 11
32572532-10623041-47963399 5389-5391 10623041 denotes 12
32572532-22517788-47963400 5842-5844 22517788 denotes 11
32572532-31324202-47963401 6820-6822 31324202 denotes 13
32572532-30481669-47963402 6922-6924 30481669 denotes 14
32572532-31046842-47963402 6922-6924 31046842 denotes 14
32572532-31046842-47963403 7059-7061 31046842 denotes 16
32572532-30076119-47963404 7303-7304 30076119 denotes 9
32572532-22895826-47963405 7583-7584 22895826 denotes 7
32572532-22152763-47963406 7586-7588 22152763 denotes 17
32572532-30076119-47963407 7688-7689 30076119 denotes 9
32572532-22895826-47963408 7783-7784 22895826 denotes 7
32572532-28387526-47963409 7786-7787 28387526 denotes 8
32572532-28647219-47963410 7789-7791 28647219 denotes 18
32572532-32392330-47963411 7969-7971 32392330 denotes 19
32572532-31894248-47963412 8028-8030 31894248 denotes 20
32572532-30299367-47963412 8028-8030 30299367 denotes 20
32572532-19935413-47963412 8028-8030 19935413 denotes 20
32572532-31077266-47963413 8349-8351 31077266 denotes 23
32572532-32160910-47963413 8349-8351 32160910 denotes 23
32572532-31905234-47963413 8349-8351 31905234 denotes 23
32572532-31177621-47963414 8451-8453 31177621 denotes 26
32572532-31169040-47963415 8706-8708 31169040 denotes 27
32572532-29635437-47963416 8912-8914 29635437 denotes 28
32572532-30616737-47963417 8916-8918 30616737 denotes 29
32572532-22895826-47963418 9738-9739 22895826 denotes 7
32572532-22895826-47963419 10224-10225 22895826 denotes 7
32572532-22895826-47963420 10649-10650 22895826 denotes 7
32572532-28387526-47963421 10754-10755 28387526 denotes 8
32572532-30076119-47963422 10757-10758 30076119 denotes 9
32572532-31102782-47963423 11398-11400 31102782 denotes 31
32572532-27177530-47963424 11632-11634 27177530 denotes 32
32572532-28387526-47963425 11817-11818 28387526 denotes 8
32572532-31292663-47963426 12116-12118 31292663 denotes 33
32572532-30580035-47963427 12780-12782 30580035 denotes 34
32572532-27365388-47963428 13877-13879 27365388 denotes 35
32572532-22895826-47963429 14547-14548 22895826 denotes 7
32572532-21107529-47963430 14550-14552 21107529 denotes 37
32572532-30076120-47963430 14550-14552 30076120 denotes 37
32572532-31939808-47963431 14703-14705 31939808 denotes 40
32572532-32160910-47963432 15045-15047 32160910 denotes 24
32572532-29090327-47963433 15323-15325 29090327 denotes 41
32572532-27365388-47963434 16369-16371 27365388 denotes 35
32572532-29544767-47963435 16373-16375 29544767 denotes 43
32572532-29544767-47963436 16612-16614 29544767 denotes 43
32572532-26282594-47963437 16616-16618 26282594 denotes 44
32572532-19361301-47963438 16934-16936 19361301 denotes 45
32572532-22610925-47963439 17239-17241 22610925 denotes 46
32572532-18171251-47963439 17239-17241 18171251 denotes 46
32572532-21768513-47963439 17239-17241 21768513 denotes 46
32572532-22751544-47963439 17239-17241 22751544 denotes 46
32572532-24550381-47963440 17445-17447 24550381 denotes 52
32572532-29544767-47963441 17637-17639 29544767 denotes 43
32572532-28717040-47963442 17989-17991 28717040 denotes 53
32572532-19361301-47963443 18214-18216 19361301 denotes 45
32572532-27365388-47963444 18417-18419 27365388 denotes 35
32572532-10525567-47963445 18421-18423 10525567 denotes 54
32572532-29544767-47963446 18834-18836 29544767 denotes 43
32572532-29623451-47963447 19029-19031 29623451 denotes 56
32572532-22517788-47963448 20457-20459 22517788 denotes 11
32572532-30076119-47963449 21113-21114 30076119 denotes 9
32572532-30299367-47963450 21116-21118 30299367 denotes 21
32572532-31469325-47963451 25490-25492 31469325 denotes 57
32572532-32160910-47963452 26452-26454 32160910 denotes 24
32572532-32339350-47963453 27968-27970 32339350 denotes 58
32572532-32339350-47963454 28178-28180 32339350 denotes 60
32572532-30076119-47963455 30383-30384 30076119 denotes 9
32572532-32339350-47963456 30429-30431 32339350 denotes 60
32572532-22895826-47963457 30474-30475 22895826 denotes 7
32572532-12890854-47963458 30549-30551 12890854 denotes 61
32572532-16554799-47963459 30753-30755 16554799 denotes 63
32572532-24563256-47963460 30888-30890 24563256 denotes 65
32572532-22895826-47963461 31110-31111 22895826 denotes 7
32572532-28387526-47963461 31110-31111 28387526 denotes 7
32572532-30076119-47963461 31110-31111 30076119 denotes 7
32572532-32339350-47963462 31176-31178 32339350 denotes 60
32572532-22895826-47963463 31243-31244 22895826 denotes 7
32572532-28387526-47963463 31243-31244 28387526 denotes 7
32572532-30076119-47963463 31243-31244 30076119 denotes 7
32572532-22895826-47963464 31363-31364 22895826 denotes 7
32572532-28387526-47963464 31363-31364 28387526 denotes 7
32572532-30076119-47963464 31363-31364 30076119 denotes 7
32572532-32339350-47963465 31440-31442 32339350 denotes 60
32572532-22895826-47963466 31470-31471 22895826 denotes 7
32572532-28387526-47963466 31470-31471 28387526 denotes 7
32572532-30076119-47963466 31470-31471 30076119 denotes 7
32572532-32339350-47963467 31533-31535 32339350 denotes 60
32572532-27709265-47963468 31670-31672 27709265 denotes 66
32572532-31986264-47963469 31733-31735 31986264 denotes 67
32572532-30076119-47963470 31821-31822 30076119 denotes 9
T48775 2620-2621 25354514 denotes 1
T15892 3039-3040 29437588 denotes 4
T86053 3147-3148 372590 denotes 6
T17737 3303-3304 22895826 denotes 7
T34194 3303-3304 28387526 denotes 7
T96222 3303-3304 30076119 denotes 7
T22940 4050-4052 22517788 denotes 11
T46095 5389-5391 10623041 denotes 12
T11193 5842-5844 22517788 denotes 11
T11106 6820-6822 31324202 denotes 13
T6909 6922-6924 30481669 denotes 14
T62848 6922-6924 31046842 denotes 14
T5649 7059-7061 31046842 denotes 16
T57717 7303-7304 30076119 denotes 9
T3279 7583-7584 22895826 denotes 7
T23163 7586-7588 22152763 denotes 17
T40850 7688-7689 30076119 denotes 9
T55810 7783-7784 22895826 denotes 7
T67977 7786-7787 28387526 denotes 8
T83444 7789-7791 28647219 denotes 18
T30057 7969-7971 32392330 denotes 19
T55659 8028-8030 31894248 denotes 20
T53000 8028-8030 30299367 denotes 20
T93641 8028-8030 19935413 denotes 20
T2230 8349-8351 31077266 denotes 23
T99335 8349-8351 32160910 denotes 23
T33839 8349-8351 31905234 denotes 23
T31495 8451-8453 31177621 denotes 26
T29746 8706-8708 31169040 denotes 27
T9365 8912-8914 29635437 denotes 28
T84093 8916-8918 30616737 denotes 29
T47034 9738-9739 22895826 denotes 7
T80169 10224-10225 22895826 denotes 7
T27000 10649-10650 22895826 denotes 7
T8508 10754-10755 28387526 denotes 8
T93633 10757-10758 30076119 denotes 9
T30112 11398-11400 31102782 denotes 31
T25822 11632-11634 27177530 denotes 32
T48506 11817-11818 28387526 denotes 8
T39271 12116-12118 31292663 denotes 33
T67090 12780-12782 30580035 denotes 34
T9256 13877-13879 27365388 denotes 35
T84490 14547-14548 22895826 denotes 7
T81142 14550-14552 21107529 denotes 37
T94939 14550-14552 30076120 denotes 37
T52886 14703-14705 31939808 denotes 40
T42293 15045-15047 32160910 denotes 24
T10315 15323-15325 29090327 denotes 41
T59357 16369-16371 27365388 denotes 35
T21297 16373-16375 29544767 denotes 43
T78250 16612-16614 29544767 denotes 43
T9616 16616-16618 26282594 denotes 44
T50130 16934-16936 19361301 denotes 45
T88155 17239-17241 22610925 denotes 46
T71393 17239-17241 18171251 denotes 46
T75852 17239-17241 21768513 denotes 46
T42515 17239-17241 22751544 denotes 46
T71499 17445-17447 24550381 denotes 52
T51946 17637-17639 29544767 denotes 43
T52416 17989-17991 28717040 denotes 53
T67943 18214-18216 19361301 denotes 45
T52492 18417-18419 27365388 denotes 35
T28103 18421-18423 10525567 denotes 54
T58235 18834-18836 29544767 denotes 43
T25290 19029-19031 29623451 denotes 56
T40827 20457-20459 22517788 denotes 11
T75357 21113-21114 30076119 denotes 9
T29496 21116-21118 30299367 denotes 21
T82735 25490-25492 31469325 denotes 57
T1408 26452-26454 32160910 denotes 24
T7855 27968-27970 32339350 denotes 58
T83290 28178-28180 32339350 denotes 60
T1239 30383-30384 30076119 denotes 9
T11993 30429-30431 32339350 denotes 60
T58330 30474-30475 22895826 denotes 7
T34258 30549-30551 12890854 denotes 61
T40916 30753-30755 16554799 denotes 63
T49447 30888-30890 24563256 denotes 65
T76577 31110-31111 22895826 denotes 7
T1286 31110-31111 28387526 denotes 7
T13233 31110-31111 30076119 denotes 7
T5897 31176-31178 32339350 denotes 60
T37794 31243-31244 22895826 denotes 7
T50031 31243-31244 28387526 denotes 7
T83601 31243-31244 30076119 denotes 7
T28555 31363-31364 22895826 denotes 7
T74628 31363-31364 28387526 denotes 7
T70095 31363-31364 30076119 denotes 7
T97225 31440-31442 32339350 denotes 60
T50555 31470-31471 22895826 denotes 7
T89999 31470-31471 28387526 denotes 7
T65385 31470-31471 30076119 denotes 7
T41608 31533-31535 32339350 denotes 60
T66653 31670-31672 27709265 denotes 66
T99520 31733-31735 31986264 denotes 67
T87804 31821-31822 30076119 denotes 9